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PREFACE
This dissertation consists of four major parts: a 
LITERATURE REVIEW, SECTION I, SECTION II, and CONCLUSIONS 
AND FUTURE STUDIES. SECTION I AND SECTION II are each 
presented in the form of a manuscript. The LITERATURE REVIEW 
is intended to provide a comprehensive review of the PFK 
literature pertinent to this study, and therefore some 
overlap may exist between this part of the dissertation and 
the introduction in SECTION I or SECTION II. The DISCUSSION 
AND FUTURE STUDIES part of this work summarizes the results 
of this research and I have proposed in this part several 
experiments to further our understanding of the regulation 
of the rmPFK gene. Again, some overlap may be found between 
this part and the discussion of either SECTION I or SECTION
II.
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ABSTRACT
Phosphofructokinase (ATP:Fructose-6-phosphate 1-phospho­
transferase, EC 2.7.1.11, PFK) catalyzes the phosphorylation 
of fructose 6-phosphate to generate fructose 1,6- 
bisphosphate, the rate-limiting step of glycolytic pathway. 
Li et al. (1990) have identified two cDNAs for the rabbit 
muscle PFK with an identical coding regions but different 5' 
untranslated regions (UTRs). In this dissertation research, 
six cDNAs for the rabbit muscle PFK mRNAs were cloned. These 
cDNAs are different in their 5' UTRs but have an identical 
open reading frame. The transcription initiation sites of 
two downstream promoters of this gene have been determined.
A proximal promoter (Pa) is TATA-less and 86 bp upstream of 
the ATG start codon. The mRNA expressed from this promoter 
has been detected in skeletal muscle and heart tissues. The 
second promoter (Pb) is skeletal muscle specific and 
produces two mRNAs (mRNA-bl and mRNA-b2) by alternative 
splicing. Part of the 5' UTR in mRNA-bl is spliced out to 
yield mRNA-b2. A fourth mRNA (mRNA-c) is also skeletal 
muscle specific.
An additional two mRNAs (mRNA-dl and -d2) are produced by 
alternative splicing. An exon of 106 bp was retained in 
mRNA-dl, but not in mRNA-d2. Interestingly, mRNA-dl was 
detected in skeletal muscle, heart, and brain, but not in 
liver and kidney tissues. Its splicing variant, mRNA-d2 is 
detected in all five tissues examined. Therefore, the 106 bp
ix
exon is retained in a tissue-specific manner. Since the 5' 
ends of mRNA-c, -dl, and -d2 are upstream of promoters a and 
b, these mRNAs can not be produced by these promoters. 
Therefore, rmPFK expresses its six mRNAs by at least three 
promoters and alternative splicing.
During the course of this research, I have developed a 
protocol for primer extension at higher temperature. In 
primer extension using M-MLV reverse transcriptase, a 
secondary structure of the RNA template was found to be 
problematic. I therefore optimized conditions for primer 
extension using thermostable DNA polymerase from Thermus 
thermophllus at high temperature. The primer extension at 
high temperature (65°C) using this enzyme reduced the 
artifact caused by the secondary structure in the RNA 
template.
x
LITERRATURE REVIEW
1
2PHOSPHOFRUCTOKIHASI 18 A RATS REGULATING ENEYMX IN 
GLYCOLYSIS
In glycolysis, glucose is degraded to generate ATP, NADH, 
and pyruvate. Pyruvate is further converted to acetyl CoA, 
providing building blocks for other synthetic reactions, 
such as the formation of long-chain fatty acids (Fig. 1). In 
glycolysis, phosphofructokinase (ATP: D-fructose-6-phosphate 
1-phosphotransferase, EC 2.7.1.11, PFK) catalyzes the 
phosphorylation of fructose-6-phosphate (F-6-P) by ATP, to 
produce fructose-1,6-bisphosphate (F-1,6-BP) and ADP 
(Bloxham and Lardy, 1973; Uyeda, 1979; Fig. 2). In metabolic 
pathways, enzymes catalyzing essentially irreversible 
reactions are potential sites of control. In glycolysis, the 
reactions catalyzed by three enzymes (hexokinase, 
phosphofructokinase, and pyruvate kinase) are irreversible. 
Therefore, these enzymes are potential sites of control in 
the glycolytic pathway. Hexokinase catalyzes the first 
irreversible reaction, the phosphorylation of glucose to 
produce glucose 6-phosphate. This product is not only a 
glycolytic intermediate, but can also be oxidized by the 
pentose phosphate pathway to generate NADPH or be converted 
into glycogen. Although PFK catalyzes the second 
irreversible reaction, this reaction is the first committed 
step in glycolysis, and therefore the most important control 
site in glycolysis (Bloxham and Lardy, 1973; Uyeda, 1979).
One of the best known examples of PFK as the control site of 
glycolysis is its role in the Pasteur effect (inhibition of
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Figure 1. The glycolytic pathway. The reaction catalyzed 
by PFK is in bold, the conversion of the glycolytic 
product pyruvate to acetyl CoA and further to fatty acids 
is shown by dashed arrows.
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pathway. Fructose 6-phosphate is phosphorylated to produce 
fructose 2,6-bisphophate.
5fermentation by oxygen). In studying fermentation of yeast, 
Pasteur found that fermentation is inhibited by oxygen. The 
rate of fermentation is about seven fold lower under aerobic 
conditions than under anaerobic conditions. This inhibition 
is largely due to the inhibition of PFK activity by ATP and 
citrate, because the product of PFK, F-1,6-BP was readily 
fermented in the presence of oxygen (reviewed in Dunaway,
1983; Bloxham and Lardy, 1973).
The physiological significance of PFK is examplified in 
the hereditary PFK deficiency in human skeletal muscle, 
known as the type VII glycogenosis, or Tarui disease (Tarui 
et al., 1965). The symptoms of this disease include 
intolerance to muscular exercise, increased hemolysis, and 
hyperuricemia (Tarui et al., 1965; Nakajima et al., 1990).
The patients with this disease have no PFK activity in their 
skeletal muscle (Tarui et al., 1965).
REGUXJkTXON OF MANHXLIAM PFK ACTIVITY BY BFFECTOR8
Mammalian PFKs are allosteric enzymes. Tetramers are the 
smallest active form for PFK isolated from mammalian sources 
(Dunaway, 1983). Each tetramer has several effector binding 
sites in addition to the substrate binding sites. Binding of 
effectors, either inhibitors or activators allosterically 
changes the kinetic properties of this enzyme. As mentioned 
above, PFK is inhibited by ATP and citrate. On the other 
hand, PFK is activated by inorganic phosphate (Pi), AMP, 
cyclic AMP, ADP, GDP, and its product F-1,6-BP. The 
regulations of mammalian PFKs by the effectors are very
6complex (Bloxham and Lardy, 1973). Here, only several major 
features of such regulations are summarized below:
1. The enzyme is inhibited by a high concentration of 
ATP .
2. The enzyme is also inhibited by citrate, an 
intermediate in the Krebs cycle. This inhibition is 
synergistic with that by ATP.
3. The inhibition by ATP can be relieved by Pi, AMP, 
cyclic AMP, ADP, F-1,6-BP, and F-2,6-BP.
4. Binding of substrate F-6-P is cooperative. Inhibitors 
decrease the affinity of PFK to F-6-P, while the activators 
increase the affinity.
The inhibition of rabbit PFK activity by ATP was first 
reported by Lardy and Parks (1956). Increasing the 
concentration of ATP above that necessary for the optimum 
catalytic activity causes a progressive decrease in PFK 
activity. This allosteric effect results from the decreased 
affinity for F-6-P upon the binding of ATP to the effector 
site. As the concentration of F-6-P is increased, the effect 
of ATP inhibition is reduced (Mansour and Ahlfors, 1968).
The inhibitory effect of ATP is counteracted by the 
metabolic degradation products of ATP, including Pi, AMP, 
and ADP (Bloxham and Lardy, 1973). Thus, PFK activity is 
closely regulated in relation to physiological conditions: 
high ATP/ADP ratio inhibits PFK activity, while high ADP/ATP 
ratio activates the PFK activity.
7The pH of the medium also affects the inhibition of ATP.
At pH 7.0 and with saturating ATP, rabbit muscle PFK is 
inhibited by ATP and exhibits sigmoidal kinetics with 
respect to F-6-P. At pH 8.0, however, ATP inhibition and 
cooperativity are not observed (Hanson et al., 1973) .
Similar results have also been reported for PFKs from brain 
(Tsai and Kemp, 1974; Lowry and Passonneau, 1966), heart 
(Mansour and Ahlfors, 1968), and liver (Kemp, 1971).
Citrate is also an important inhibitor of PFK activity.
This links the regulation of glycolysis with the Krebs 
cycle. Using rat heart PFK, Garland et al. (1963) found that 
citrate is the only Krebs cycle intermediate effective in 
inhibiting PFK activity. However, muscle PFK has been found 
to be inhibited also by isocitrate, though less than by 
titrate (Parmeagiani and Bowman, 1963). Rat brain PFK is 
inhibited by most of the Krebs cycle intermediates, 
including cis-aconitate, isocitrate, malate, succinate, and 
a-ketoglutarate (Passonneau and Lowry, 1963). Tsai and Kemp
(1974) observed that rabbit muscle PFK is more sensitive to 
citrate inhibition than the liver or brain PFK. The 
inhibition by citrate has been shown to be synergistic to 
that of ATP (Passonneau and Lowry, 1963). Mammalian PFK is 
also inhibited by several other phosphorylated 
intermediates, including phosphocreatine,
3-phosphoglycerate, 2,3-bisphosphoglycerate, and 
phosphoenolpyruvate (Bloxham and Lardy, 1973; Uyeda, 1979).
The inhibition by these inhibitors is most pronounced in the
8presence of an inhibitory concentration of ATP (Colombo et 
al., 1975),
The inhibition by ATP and other negative effectors can be 
counteracted by AMP, cAMP, ADP, Pi, F-6-P, and F-1,6-BP 
(Uyeda, 1979; Pilkis et al., 1981). F-1,6-BP is the 
strongest activator. The activation of PFK by positive 
effectors are synergistic. For instance, activation by 
F-1,6-BP is enhanced by AMP (Tornheim and Lowenstein, 1976).
ADP alone is a weak activator and the presence of Pi greatly 
enhances the activation by ADP (Passonneau and Lowry, 1963) .
In the early 1980s, a new regulator of glycolysis was 
discovered (Van Schaftingen et al., 1980; Claus et al. 1981; 
Uyeda et al., 1981). Van Schaftingen et al.(1980) found that 
fl-D—fructose-2, 6-bisphosphate (F-2,6-BP), a previously
unknown metabolite, is a positive effector of PFK. Like 
other positive effectors, F-2,6-BP activates PFK by 
increasing its affinity for F-6-P and relieving the 
inhibitory effect of ATP. This effector is the most potent 
activator known. For the liver PFK, the concentration of 
F-2,6-BP needed to achieve a half-maximal stimulation is 
1000 times lower than that of F-1,6-BP required to obtain 
the same effect (Van Schaftingen et al., 1980). The affinity 
of the rabbit muscle PFK for F-2,6-BP is approximately 10 
fold higher than that for F-1,6-BP (Foe et al., 1983).
The level of F-2,6-BP has been shown to be regulated by 
hormones. Insulin and epinephrine, both of which stimulate 
lactate production, also increase the concentration of
9F-2,6-BP. F-2,6-BP is synthesized and degraded by
6-phosphofructo-2-kinase/fructose-2,6-bisphophatase 
(6PF-2-K/F-2,6-BPase), a bifunctional protein. The two 
reactions are catalyzed at two discrete active sites. 
6PF-2-K/F-2,6-BPase is a dimeric protein and is regulated by 
reversible phosphorylation (Pilkis, 1990) . The hormones 
regulate the F-2,6-BP level by phosphorylating or 
dephosphorylating the protein via a cyclic AMP mediated 
signal transduction pathway (Pilkis and El-Maghrabi, 1988). 
MAMMALIAN PFK EXISTS AS THREE ISOZYMES
The possible existence of isozymes of mammalian PFK was 
first implicated in the aforementhioned Tarui disease that 
is characterized by lack of muscle PFK activity (Tarui et 
al., 1965; Layzer et al,, 1967). In patients with this 
disease, although the muscle PFK activity was reduced to 
zero, erythrocyte PFK activities were half of normal, and 
the PFK activities in white blood cells were unaffected 
(Layzer et al., 1967). Immunological studies showed that an 
antibody against human muscle PFK failed to inhibit 
erythrocyte PFK from these patients, while normal 
erythrocyte PFK activity was inhibited approximately 40%
(Layzer et al., 1969; Tarui et al., 1969). These 
observations suggest that the enzymes from muscle and 
erythrocyte are products of different genes.
In rabbit tissues, there are three isozymes (Foe and 
Kemp, 1985; Gonzalez and Kemp, 1978; Tsai and Kemp, 1973;
1974; Kemp, 1971). The three isozymes purified from
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different tissues were named as M from muscle, L from liver, 
and C from brain (Kemp, 1971; Tsai and Kemp, 1974; Foe and 
Kemp, 1985). The apparent monomer molecular weight of the L,
M, and C subunits are 80,000, 85,000, and 87,500, 
respectively (Dunaway, 1983). The three isozymes are 
immunologically distinct. Antiserum against purified muscle 
PFK removed 98% activity from solution containing purified 
muscle PFK, but removed only partial activity (32%) of 
purified liver enzyme. Antiserum against purified liver PFK 
removed 96% activity of the purified liver PFK, but removed 
a mere 3% activity of the purified muscle enzyme. The 
combination of both antisera did not remove all the brain 
PFK activity, because the C type isozyme also is found in 
this organ (Tsai and Kemp, 1973). Antisera raised against 
muscle or liver PFK removed litle purified PFK C activity 
(Foe and Kemp, 1985). When the protomers of acid dissociated 
muscle and liver PFK recombine at neutral pH, they form 
three electrophoretically distinct isozymes in addition to 
the two parent enzymes. This result agrees with the concept 
that muscle and liver PFKs are different proteins. The three 
hybrids are be M3L, L3M, and M2L2 (Gozaie2 and Kemp, 1978),
In human and rat tissues, there are also three isozymes 
(Dunaway, et al., 1988; Dunaway and Kasten, 1987). in 
general, mammalian PFK exists as a homo- or hetero-tetramer 
of the three subunits, depending on the abundance of the 
three subunits in a given tissue (Dunaway, 1983).
11
MAMMALIAN PFKS ARC HIGHLY CONSERVED
The complete primary structures of the three isozymes of 
mammalian PFKs have been determined. The M isozyme has been 
cloned and sequenced from rabbit (Poorman et al., 1984; Lee 
et al., 1987), mouse (Gehnrich et al., 1988), and human 
muscles (Sharma et al., 1989). The L isozyme has been cloned 
and sequenced from rat (Hotta et al., 1991), mouse (Gekakis 
et al, 1989), and human (Levanon et al., 1989) livers. The C 
isozyme has been determined from rabbit (Li et al., 1994), 
and rat (Gekakis et al., 1994) tissues.
Comparison of the amino acid sequences of the three types
of mammalian PFK isozymes indicates that all mammalian PFKs
are highly homologous: there is more than 65% ammino acid
sequence identity among the cloned mammalian PFK isozymes
(Gekakis et al., 1994). Interestingly, there is higher
sequence identity between the same type of isozymes from
different species than between two types of isozymes from
the same species. For example, there is only 68.9% amino
acid sequence identity between rabbit M and C type PFKs,
while there is 90% sequence identity between the rabbit
muscle and mouse muscle PFKs (Lee et al., 1987; Gehnrich et
al., 1988; Li et al., 1994). Perhaps, different PFK isozymes
evolved before the mammals diversified.
TISSUE SPECIFICITY OF THE PFK ISOEYMES AT THE 
PROTEIN LEVEL
The levels of the three PFK subunits in mammalian tissues 
have been studied by SDS-polyacrylamide gel electrophoresis
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and immunoprecipitation with antisera raised against each 
type of subunit. The tissue-specific distributions of the 
three types of PFK isozymes in human, rabbit, and rat are 
summarized in Table 1. In skeletal muscle, only the M 
subunit has been detected in rabbit (Tsai and Kemp, 1973), 
rat (Dunaway and Kasten, 1987), and human (Dunaway et al.,
1988). In liver, the L type subunit is the predominant form.
But there are small amounts of the M type subunit in rabbit 
(Tsai and Kemp, 1973), and rat liver (Dunaway and Kasten,
1987), and small amounts of the M and C type subunits in 
human liver (Dunaway et aJ., 1988). The M type PFK is the 
major form in the heart of all three mammals, along with L 
and C type subunits (Tsai and Kemp, 1973; Dunaway et al.,
1988; Dunaway and Kasten, 1987). In the brain and kidney of 
rabbit (Tsai and Kemp, 1973), rat (Dunaway and Kasten,
1987), and human (Dunaway et al., 1988), all three types of 
subunits co-exist. The three subunits have also been 
detected in other rat tissues, such as lung, thyroid, and 
spleen (Dunaway and Kasten, 1987).
THE DISTINCT KINETIC PROPERTIES OF THE THREE 
MAMMALIAN PFK ISOZYMES
Kemp (1971) observed that the rabbit muscle and liver 
PFKS are different kinetically. He found that the liver 
enzyme is more sensitive to ATP and 2,3-diphosphoglycerate 
inhibition, less sensitive to citrate and phosphoenopyruvate 
(PEP) inhibition, and less sensitive to activation by AMP,
ADP, and cAMP. He concluded from these results that liver
Table 1. Tissue-specific expression patterns of the three mammalian PFK 
isozymes in human, rabbit, and rat tissues.
Isozyme
Human* 
M L K H B
R abbitb 
M L K H B
R atc 
M L K H B
C-type + •M- +♦ •M+ ♦+ ♦+ +++
M-type +♦++ + ** ■M+ ♦+++ * ++ +++
L-type ♦♦♦» ** ♦+ ++++ ++ ++ ++
•: Dunaway et al. (1988). 
b: Tsai and Kemp (1973). 
c: Dunaway and Kastan (1987).
M: muscle; L: liver; K: kidney; H: heart; B: brain.
++++: predominant (>80%); +++: major (50-70%); ++: abundant (10 -40%); 
+ : small amount (<10%).
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PFK was less suited for anaerobic energy production than 
muscle PFK. Gonzalez and Kemp (1978) compared the kinetics 
of the M2L2 hybrid isozyme of rabbit PFK with those of the 
M4 and L4 isozymes. They found that ATP inhibition to the 
hybrid enzyme is intermediate between that observed with M4 
and L4 and is clearly not identical to a simple summing of 
the effects of M and L subunits. The inhibitions to the M2L2 
hybrid by citrate, 2,3-diphosphoglycerate, and 
phosphocreatine are also intermediate between those observed 
with M4 and L4.
The kinetic properties of the C type PFK remained elusive 
for a while, partly because it co-exists with the other two 
isozymes in a given tissue, such as brain, which makes it 
more difficult to purify. Almost a dacade and a half after 
purification of the M and L isozymes, Foe and Kemp (1965) 
successfully purified PFK C from rabbit brain. They found 
that this isozyme is kinetically distinct from the M and L 
isozymes. The C isozyme is more sensitive than the M isozyme 
but less sensitive than the L isozyme to ATP inhibition. The 
inhibition by citrate is opposite: the C isozyme is less 
sensitive than the M isozyme but more sensitive than the L 
isozyme to citrate inhibition, PFK M is the most sensitive 
isozyme to activations by Pi, AMP, ADP and F-2,6~BP, while 
isozyme C is the least sensitive to these activators (Foe 
and Kemp, 1985). They again noted that the kinetic 
properties of PFK hetero-tetramers are probably influenced 
by interactions between the different subunits, since their
15
kinetics cannot be predicted from the properties of the 
homo-tetramers.
These distinct kinetic properties of the three mammalian 
isozymes probably evolved according to the physiological 
requirement of glycolytic regulation in a given tissue. For 
example, PFK M is the least sensitive to ATP inhibition but 
the most sensitive to positive effectors such as AMP, ADP, 
and F-2,6-BP. This fits well with the physiology of muscle, 
where ATP is produced and utilized for muscle movement. 
Hepatocytes have very different requirements since they must 
be capable of carrying out gluconeogenesis in order to 
maintain blood glucose levels. Citrate and other Krebs cycle 
intermediates are also precursors in gluconeogenesis. They 
are oxidized to yield oxaloacetate, which in turn is 
converted into phosphoenolpyruvate, an intermediate in 
gluconeogenesis. Therefore, the L type PFK, the least 
sensitive to citrate inhibition, allows glycolysis and 
gluconeogenesis to be carried out in the hepatocytes.
STRUCTURE OF BACTERIAL PVKS
The structure of the bacterial PFK is reviewed here for 
two reasons. First, the three-dimensional structure of 
mammalian PFK has not been determined. Second, mammalian 
PFKs probably evolved by gene duplication, because the N- 
and C-terminal halves of the rabbit muscle PFK are 
homologous to each other and to bacterial PFKs (Poorman et 
al., 1984; Lee et al., 1967), Poorman et al. (1984) proposed 
a model structure of the rabbit muscle PFK based on the
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structure of bacterial PFK (I will come back to this in more 
detail later).
PFK from Bacillus stearothermophllus and that from 
Eschericha coll are highly homologous, with 53% amino acid 
identity. The E . coli PFK (EcPFK) shows sigmoidal kinetics 
with respect to one substrate, F-6-P, but not to the other 
substrate, ATP. It is allosterically inhibited by PEP, and 
allosterically activated by ADP or GDP. The B. stearother- 
mophllus PFK (BsPFK) behaves similarly, except that the 
kinetics with respect to F-6-P are sigmoidal only in the 
presence of PEP. In the absence of PEP, it is hypobolic 
(Valdez et al., 1989a).
The three-dimensional structures of EcPFK and BsPFK have 
been determined using X-ray crystallography (Evans et al.,
1981; Shirakihara and Evans, 1988; Schirmer and Evans,
1990). The structure of the enzyme bound to substrate and 
effector reveals the mechanism of the catalysis and the 
effector binding. Comparison of the structures of the BsPFK 
in the relaxed (R) and tight (T) states shows how the 
conformation is changed before and after the allosteric 
transition, which provides insight into the mechanism of the 
allosteric behavior of PFK (Schirmer and Evans, 1990).
Both E. coli and B. stearothermophilus PFKs are tetramers 
of identical subunits with 319 amino acids each. Each 
subunit consists of two domains: a larger one which binds 
the substrate ATP, and a smaller one which binds the other 
substrate F-6-P. Each domain is a 3-layered ap a  sandwich
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structure. The tetramer is a dimer of dimers: two subunits 
pack together with a large interface to form dimers 
(subunits AB or CD in Fig. 3) and two dimers pack together 
with a smaller interface to form the tetramer. The tetramer 
exhibits 222 symmetry: the three molecular dyad axes are p, 
q, and r (Fig. 3).
The active site lies between the two domains of each 
subunit: the ATP binding site is formed almost entirely by 
residues of the large domain and the F-6-P binding site 
consists of residues mainly from the small domain 
(Shirakihara and Evans, 1988). The catalytic site is located 
between the two domains, while the effector site lies in the 
larger interface between the two subunits within each dimer 
(Schirmer and Evans, 1990).
STRUCTURE DIFFERENCES OF BSPFK IN THE R AMD T STATES
When the structures of the R and T states are 
superimposed on their 222 axes, the major difference is the 
rotation of the AB dimer relative to the CD dimer by about 
7° (Fig. 3). The rotation axis is close to the molecular p 
dyad (the symmetry axis of the dimers). Not much rotation is 
seen between the two subunits of the dimer, because of the 
much larger contact area between subunits within the dimer 
as compared to that between dimers. Although no significant 
change has been noted at the large interface of the two 
subunits within the dimer, an additional hydrogen bond 
exists between the subunits in the T state. Asp 59 interacts 
with the ribose of the effector ADP in the R structure, and
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Figure 3 . Diagram depicting the general view of BsPFK and 
its quaternary and tertiary structure changes on the 
allosteric transition from R to T, a. Schematic sketch of 
the R-state (dashed outline) and T-state (solid outline) 
PFK tetramer, viewed along p. The three mutually 
perpendicular 2-fold symmetry axes are labeled p, g and r. 
The subunits are labeled A-D. Residues labeled with * 
belong to subunit A, all others to subunit D. b, same as 
in a but viewed from r and additional presentation of the 
ligands of the R structure. (adapted from Schirmer and 
Evens, 1990). e, R-state structure, subunits A and D, 
related by r dyad, viewed as in b. helices are presented 
as cylinders numbered 1-13, 0-sheet strands as arrows 
labeled A-K. In the active site the substate F-6-P and the 
product ADP are shown, in the effector site the activator 
ADP (Shirmer and Evens, 1990). (Reprinted with permission 
from Nature 343, 140-145; Copyright (c) 1990 MacMillan 
Magazines Limited)
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is hydrogen bonded to His 215 in the neighboring subunit. On 
the other hand, the interface between the two dimers 
triggers and accommodates their relative rotation in the 
allosteric transition. On transition from the R to the T 
state, the rigid dimers undergo a contrary rotation around 
their common dyad axis. This motion couples the changes in 
the four binding sites for the cooperative substrate F-6-P, 
which lie between dimers. The rotation of the dimers is 
accommodated by removal of the layer of water molecules that 
lie between the dimers in the R structure, and by 
restructuring the 6-F loop (residues 155-162).
The rearrangement of the 6-F loop couples the binding of 
F-6-P to the quaternary structure change, and to the binding 
of heterotropic effectors (Fig. 4). When molecules with 
opposite allosteric effects bind to the effector site, most 
of the site remains unchanged. Only the 8-H loop (residue 
213-215) moves in response to a change of effector. This 
movement is coupled to the rearrangement of the 6-F loop.
The low-affinity T-state conformation can only be formed 
when the lips of the effector site are closed. This closure 
is induced by inhibitors, but cannot occur when the larger 
activator ADP is bound, hence the opposite effects (Schirmer 
and Evans, 1990).
STRUCTURE OF MAMMALIAN PFKS
Each subunit of Mammalian PFK has a molecular mass of 
85±5 kDa, about twice that of its bacterial counterpart (37 
kDa). Examination of the amino acid sequence of rabbit
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Figure 4. Schematic view of the 6-F loop (residues 155- 
162) of BsPFK showing its different interactions across 
the interface between dimers. The wavy line represents 
part of the boundary between r-dyad-related subunits 
(i.e., the boundary between dimers), a, T structure, 
showing Glu 161 in the F-6-P site, the arg 72-Glu 241 salt 
bridge, b, R structur (with bound ligands ADP and F-6-P), 
showing the phosphate of F-6-P bound by Arg 162 and Arg 
243. (Shirmer and Evens, 1990). (Reprinted with permission 
from Nature 343, 140-145; Copyright (c) 1990 MaMillan 
Magazines Limited)
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muscle PFK has revealed that its N-terminal and C-terminal 
halves are homologous to each other (30% identity). The two 
halves of the rmPFK are also homologous to bacterial PFK: 
there are 42% and 33% identities between the amino acid 
sequence of BsPFK and those of the N- and C-terminal halves 
of rmPFK, respectively (Fig. 5). These data suggest that the 
mammalian enzyme evolved from a prokaryotic progenitor by 
gene duplication and divergence (Poorman et al., 1984; Lee 
et al., 1987). Based upon the sequence data, Poorman et al. 
(1984) proposed that the tertiary structure of each rmPFK 
subunit consists of two "super" domains, each closely 
resembling the structure of the BsPFK monomer, joined by a 
connecting peptide of about 30 residues. Therefore, a 
tetramer of mammalian PFK is equivalent to an octomer of 
bacterial PFK. Yet, there are only four F-6-P binding sites 
in a tetramer of mammalian PFK. In addition to the four F-6- 
P binding sites, there are four binding sites for F-1,6-BP 
or F-2,6-BP (Fig. 6), but none in bacterial PFK. This is 
probably the structural basis why the bacterial PFKs are not 
allosterically regulated by either F-1,6-BP or F-2,6-BP. 
Homology in the vicinity of Asp-127 in BsPFK, a residue 
involved in F-6-P binding, is clearly evident in the N- 
terminal half of rmPFK but not in the C-terminal half, where 
the corresponding residue is a serine. Poorman et al. (1984)
postulated that the F-6-P binding site in the C-terminal 
half of rmPFK has evolved as an effector site for either 
F-1,6-BP or F-2,6-BP, This seems reasonable as Asp-127 is
23
Figure S. Sequence comparison of homologous PFKs and 
position of introns along the amino acid sequence of 
rabbit muscle PFK. The amino sequence of E. coli PFK 
(Ec PFK-1), B . stearothermophilus PFK Bs PFK), and the N- 
half [RM-PFK (N)) and C-half [RM-PFK (C)] of the rabbit 
muscle PFK are aligned for maximum homology. Double headed 
arrows above the sequences indicate secondary structural 
elements found in BsPFK. Introns (solid triangles in the 
N- and C- halves of the rabbit muscle PFK are positioned 
between the respective amino acid residues. Underlined 
regions are those deduced from DNA sequence of the rmPFK 
gene.(modified from Hellinga and Evens, 1985 with 
permission)
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C-HALF. SUBUNIT 2 N- AND C-HALVES O F A SINGLE SUSUMT
y.ifj
« m
N-HALF SUBUMT 1
Figure 6 . Location of substrate and effector sites in the 
hypothetic rmPFK protein model. Residues enclosed in solid 
boxes are identical to those at corresponding positions in 
BsPFK; those enclosed in dotted boxes are different (Taken 
with permission from Poorman et al., 1984)
26
probably required as a base catalyst acting to increase the 
nucleophilicity of the 0-1 hydroxyl of F-6-P for attack on 
the y-phosphate of ATP. Its presence would cause
electrostatic repulsion of F-1,6-BP or F-2,6-BP. Replacement 
of Asp-127 by Ser in the C-terminal half would remove this 
negative charge and provide more room for binding of the F-
1,6-BP and F-2,6-BP, which are known to compete for a common 
site (Foe et al., 1983), Poorman et al. (1984) suggested 
that the replacement of a catalytically essential Asp-127 
has led to loss of a catalytic site and creation of an 
allosteric site for F-1,6-BP or F-2,6-BP activation.
MAMMAL I AM PFK GENES
The first mammalian PFK gene cloned was the rabbit muscle 
PFK (Lee et al., 1987). The organization of the rabbit 
muscle PFK gene is shown in Figure 7, This gene has 22 
coding exons, spanning 17 kp (Lee et al., 1987). When 
overlaid on the structure of the protein, most of the 
introns are located between or near the ends of the 
secondary structural elements. Although the two halves of 
the PFK are homologous to each other in amino acid sequence, 
the introns located in the carboxyl-terminal half of the 
gene are not located at positions analogous to those in the 
amino-terminal half (Lee et al., 1987).
Subsequently to the cloning of the rabbit muscle PFK 
gene, the mouse liver gene (Rongnoparut et al., 1991) and 
human muscle gene (Yamasaki et al., 1991) have been cloned. 
Comparison of these three cloned mammalian PFK genes showed
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Figure 7. Exon/intron organization of the rabbit muscle 
PFK gene and comparison of the 5' UTRs of two rabbit and 
three human muscle PFK cDNAs, a. The complete exon/intron 
organization of the rmPFK gene. Solid boxes: coding exon 1 
through XXII; open boxes: 5' UTR. The 1.69 kb intron in 
rmPFK cDNA-A is indicated by the downward bent line. The 
open box with a broken end indicates a UTR, the 5' end of 
which is not known, b. Three cDNAs for the human muscle 
PFK. The dashed line and box indicate an intron with 
unknown length and 5' UTR (Modified from Li et al, 1990),
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that the exon-intron organizations of these genes are 
similar with respect to the exon sizes and positions/ with 
only one exception: exon 13 in mouse liver gene is three 
nucleotides (1 amino acid) shorter than those in rabbit and 
human muscle gene. However, the sizes of the introns in the 
three genes are not conserved.
TWO CDNAS Or THI RABBIT MUSCLE PFK WITB DIVERGED 
5' UNTRANSLATED REGIONS (UTRS)
Previous work in the Chang Laboratory has 
identified two cDNAs for rmPFK (Li et al., 1990). These 
two cDNAs have identical coding regions, but 
different 5' untranslated regions (Figs. 7 and 8; Li 
et al., 1990). Alignment of the cDNA sequences with 
that of the genomic DNA showed that there is an intron 
spliced out in the 5' untranslated region of one of the 
two cDNAs (Fig. 7). These cDNAs could be derived from 
one promoter and alternative splicing of the pre-mRNA. 
Alternatively, they could be produced by two different 
promoters.
EUKARYOTIC PRE-nRMA SPLICING IS FACILITATED BY 
SPLICEOSOME
Since the two rmPFK cDNAs could be derived by alternative 
splicing, the splicing of pre-mRNA and subsequently the 
regulation of alternative splicing are reviewed here.
Splicing of eukaryotic precursor messenger RNA (pre-mRNA) 
is a two-step transesterification reaction which precisely 
removes the introns and joins exons. The first cleavage 
occurs at the 5' splice site, forming cleaved exon I and
29
cDNA-A CTCTCCGGAG CSTATAAAACG TGAGAGGGGC AGCCTGCTGA CCCCCAATCT
cDNA-A AGTCCAAACC CTTCTTAGTG CATAAGAAGC TGTTCAAGTC CCACACAAGG
c d n a -B TGTCC TAACTGACCA TCGTCTTGCC
cDNA-A TATTAOAflTG CATC A T Q  ACC C A T_O A A ____
cDNA-B TTCTAOAOTQ OATC AT Q ACC C A T-O A A ----
M  T  ■  X ----
Figure 8 . Sequence diversity in the 5' UTRs of two rmPFK 
cDNAs Bold prints indicate identical sequences. Plain 
prints are divergent sequence. "TATA" sequence is 
underlined. Coding sequences downstream of ATG are 
identical in the two rmPFK cDNAs. M, methionine; T, 
threonine; H, histidine; E, glutamic acid. (Modified from 
Li et al, 1990)
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lariat intron-second exon intermediates. This is followed by 
a second cleavage at the 3' splice site, the concomitant 
joining of the two exons, and the release of the intron in 
a lariat form (for recent reviews, seeGreen, 1991; Steitz,
1992; Moore et al., 1993).
The splicing of pre-mRNA is facilitated by the 
spliceosome, which is formed by the assembly onto the pre- 
mRNA of five small ribonucleoprotein particles (Ul, U2, U4,
U5, and U6 snRNPs). The assembly of spliceosome in mammalian 
cells depends on a consensus sequence at the 5' splice site, 
a branch point sequence and the adjacent polypyrimidine 
tract, and the 3' AG dinucleotide. The assembly of the 
spliceosome starts with the binding of Ul snRNP to the 5' 
splice site of the pre-mRNA. This recognition is facilitated 
by base-pairing between the 5' end of Ul snRNA and the 5' 
splice site (Siliciano and Guthrie, 1980). The second step 
is the binding of U2 snRNP to the pre-mRNA branch site. 
Base-pairing between U2 snRNA and the branch site of pre- 
mRNA is involved in this recognition (Wu and Manley, 1989).
The biding of U2 auxiliary factor (U2AF) to the 
polypyrimidine tract near the 3' splice site is also 
required for this U2 snRNP-pre-mRNA interaction (Green,
1991). The final step of the spliceosome assembly is the 
entry of U4/U6/U5 tri-snRNPs (Steitz, 1992; Moore et al.,
1993; Green, 1951). U5 snRNA interacts with sequences at 
both the 5' and 3' splice sites (Newman and Norman, 1992; 
Wassarman and Steitz, 1992) . U6 snRNA has also been found to
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interact with the intron sequence at the 5' splice site 
(Wassarman and Steitz, 1992). Furthermore, the base-pairing 
between the U6 snRNA and the 5' splice site sequence has 
been shown to be important and necessary in the 5' splice 
site selection (Lesser and Guthrie, 1993; Kandels-Lewis and 
Seraphin, 1993).
Several non-snRNP proteins are also required in the pre- 
mRNA splicing (Lamm and Lamond, 1993). The cytoplsmic 
extract S100 was found to be imcompetent in in vitro 
splicing assay, although it contains all the snRNPs required 
for pre-mRNA splicing. Addition of alternative splicing 
factor/splicing factor 2 (ASF/SF2) is sufficient to render 
the S100 extract splicing competent (Ge and Manley, 1990; 
Krainer et al., 1990). ASF/SF2 is a member of the SR protein 
family, which includes SRp20, ASF/SF2, SC35, SRp40, SRp55, 
and SRp70 in mammals (Zuo and Manley, 1993; Ge and Manley,
1990; Ge et al.,1991; Krainer et al., 1990, 1991; Zahler et 
al., 1992; 1993; Mayeda and Krainer 1992; Mayeda et al.,
1992, 1993; Fu et al., 1992). These proteins contain one or 
more RNP-type consensus sequence (RNP-CS) and sequences of 
consecutive arginine (R) and serine (S) dipeptides (RS 
domain). ASF/SF2 and SC35 are involved in the commitment 
complex (containing pre-mRNA and Ul snRNP) formation (Kohtz 
et al., 1994; Fu, 1993), by binding to the 5' splice site 
(Zuo and Manley, 1994). ASF/SF2 can bind to Ul snRNP, and 
more specifically, to the integral Ul 70k protein (Kohtz et 
al., 1994; Wu and Maniatis, 1993). This protein-protein
interaction cooperates in the binding of Ul snRNP and 
ASF/SF2 to the pre-mRNA (Kohtz et al., 1994). ASF/SF2 and 
SC35 are also shown to interact with the 35K subunit of 
U2AF, which binds to the polypyrimidine tract near the 3' 
splice site. This interaction is thought to bridge the 5' 
and 3' splice sites (Hu and Maniatis, 1993).
REGULATED ALTERNATIVE SPLICING IN HIGHER EUKARYOTES
Utilizing alternative 5' or 3' splice sites results in 
alternative splicing of pre-mRNAs. Alternative splicing of 
many genes has been reported to play important roles in 
developmental and cellular processes of higher organisms 
(for recent reviews, see Maniatis, 1991; Green, 1991; Nadal 
Ginard et al., 1991; Rio, 1992). For example, the sex 
determination of Drosophila melanogaster requires sex- 
specific alternative splicing of at least three genes that 
are involved in this process (Fig. 9; Baker, 1989). Another 
example is the alternative splicing of HIV RNA which plays 
important roles in HIV proliferation (Chang and Sharp,
1989). Finally, alternatively spliced CD44, a cell adhesion 
molecule, potentiates tumor metastasis (Gunthert et al., 
1991; Rudy et al., 1993).
Sex-specific alternative splicing of several genes plays 
a pivotal role in Drosophila somatic sex determination (Fig 
9), These genes are Sex-lethal (Sxl), transformer (tra), 
and double sex (dxs). First, Sxl protein autoregulates its 
own splicing. In female flies, Sxl protein blocks the usage 
of the 3' splice site of intron 2 of Sxl pre-mRNA. This
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Figure 9. Alternative splicing in Drosophila somatic cell 
sex determination. The exon-intron organizations and the 
splicing pathways of Sxl, tra, and dsx are diagramed in 
the middle. The female-specific pathway depicted at the 
top, while the default pathway at the bottom. The products 
of the female-specific splicing pathways are diagramed on 
the left and those of the default splicing on the right. 
Sxl: sex lethal; tra: transformer; tra2: transformer 2; 
dsx: double sex. Open box with number: exon; solid line: 
intron. At the bottom, female form of dsx protein 
represses the functions of the male differentiation genes, 
while the male form dsx protein represses the functions of 
the female differentiation genes.
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leads to the splicing of exon 2 onto exon 4, resulting in 
Sxl mRNA with exon 3 skipped. In the male flies, exon 3 is 
retained by default and no functional Sxl protein is 
produced because there is a stop codon in exon 3 (Fig. 9).
The alternative splicing of tra is also regulated by Sxl 
protein in a similar way and functional Tra protein is only 
produced in female flies (Fig. 9). Tra, along with the 
product of transformer 2 (tra2) gene, in turn regulates the 
alternative splicing of dsx. Unlike Sxl and tra, dsx encodes 
two forms of proteins. The female form is required to 
supress male differentiation in the female flies, while the 
male form is required to supress female differentiation in 
the male flies (Fig. 9). These two forms are generated by 
alternative splicing of its pre-mRNA by using alternative 3' 
splice sites. Tra and Tra2 proteins activate the female- 
specific splicing of dsx pre-mRNA by forming a protein 
complex on a splicing enhancer located 300 bp downstream of 
the female-specific 3' splice site (Tian and Maniatis,
1993).
A well studied pre-mRNA alternative splicing in mammalian 
cells is the splicing of human immunodeficiency virus type 1 
(HIV-1) precursor RNA. In HIV infected cells, the full- 
length 9-kb viral transcript is spliced inefficiently to 
yield several classes of mRNAs that include the unspliced 9- 
kb mRNA and singly spliced 4-kb mRNAs (which encode 
structural viral proteins), and doubly spliced 2-kb mRNAs.
The 9-kb and the 4-kb mRNAs contain functional introns and
splice sites, and their appearance in the cytoplasm is 
absolutely denpendent on the viral trans-activator Rev 
protein (Chang and Sharp, 1989}. Without Rev protein, the 
expression of the structural viral proteins (and hence the 
virus proliferation) is inhibited. Rev mediates its function 
through a cis-acting RNA sequence termed Rev-responsive 
element (RRE), which is located in the env gene of HIV-1 and 
in the unspliced intron of the 9-kb and 4-kb class mRNAs. 
Until recently, it is not clear whether Rev-mediated 
cytoplasmic expression of the unspliced, RRE-containing RNA 
is due to the inhibition by Rev of the splicing of RRE- 
containing intron, or due to the Rev-facilitated export of 
RRE-containg RNA, or both. Using an in v'itro splicing 
system, Kjem et al. (1991) tested whether Rev inhibits pre- 
mRNA splicing. These researchers found that Rev inhibits 
pre-mRNA splicing in an RRE dependent manner. On the other 
hand, the splicing of RRE-containing pre-mRNA is not 
inhibited with the absence of Rev protein. Further more,
Kjem and Sharp (1993) have showed that Rev inhibits RRE- 
containing RNA splicing by blocking the entry of U4/U6/U5 
tri-snRNP during spliceosome assmbly. On the other hand, 
Fisher et al. (1994) have demonstrated that Rev directly 
promotes the nuclear export of unspliced RNA, Therefore, Rev 
functions by both inhibiting the splicing and the export to 
cytoplasm of RRE-containing, unspliced or singly spliced HIV 
RNAs.
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Several mammalian SR proteins have been shown to regulate 
pre-mRNA alternative splicing. ASF/SF2 and SC35 promote the 
use of the proximal 5' splice site among two competing 
alternative 5' splice sites, while SRp40, SRp55, and SRp70 
promote the use of the distal 5' splice site in vitro (Zuo 
and Manley, 1993; Ge and Manley, 1990; Ge et al., 1991;
Krainer et al., 1990; Mayeda and Krainer 1992; Mayeda et 
al., 1992, 1993; Fu et al., 1992; Zahler et al., 1993). The 
RS domain of ASF/SF2 was found essential for its splicing 
factor activity but not for splice site switching (Zuo and 
Manley, 1993). ASF/SF2 and SC35 also favor the proximal site 
in a pre-mRNA containing duplicated 3' splice sites (Fu et 
al., 1992).
In addition to SR proteins, another cellular RNA binding 
protein, the heterogeneous nuclear ribonucleoprotein Al 
(hnRNP Al), has also been found to regulate pre-mRNA 
alternative splicing. This protein promotes the use of the 
distal 5' splice site, which is antagonistic to ASF/SF2 
(Mayeda and Krainer, 1992).
MULTIPLE PROMOTERS OP PROTEIN ENCODING GENES
The two rmPFK cDNAs (Li et al., 1990) could be produced 
by two seperate promoters. Therefore, studies on multiple 
promoters of eukaryotic genes are reviewed here.
Most mammalian genes encoding proteins are transcribed 
from one promoter. However, an increasing number of genes 
have been reported to have more than one promoter (for 
review, see Schibler and Sierra, 1987). For example, the
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gene encoding the 6-phosphofructo-2-kinase/Fructose-2,6- 
bisphosphotase (6PF-2-K/F-2,6-BPase) is transcribed by two 
tissue-specific alternative promoters: a downstream promoter 
transcribes the gene in the liver, while an upstream 
promoter expresses the gene in the muscle (Darville et al., 
1989). F-6-P-2-K/F-2,6-BPase catalyzes the synthesis and 
degradation of F-2,6-BP, a very potent activator of 
mammalian PFK. Human aldolase A gene, whose product is also 
involved in glycolysis, is transcribed by three alternative 
promoters (Gautron et al., 1991). Mouse y-glutamyl-
transferase gene expresses its six mRNAs from five 
promoters, three of which are kidney specific (Rajagopalan 
et al., 1993; Sepulveda et al., 1994). The human carbonic 
anhydrase I gene contains two promoters with different 
tissue specificities (Brady et al., 1991). Multiple promoter 
usage has also been observed in mouse glucocorticoid 
receptor gene (Strahle et al., 1992), rat dopamine-D2- 
receptor gene (Valdenaire et al., 1994), and rat liver 
alkaline phosphatase gene (Toh et al., 1989).
What is the advantage of having multiple promoters for a 
gene? In transcribing a single gene from multiple promoters, 
an organism gains additional flexibility in controlling the 
expression of the gene. In higher eukaryotes, multiple 
promoters are usually associated with tissue- and/or 
developmental stage-specific expression of the genes. As 
mentioned above, functional Sxl protein is required to 
regulate the alternative splicing of its own and tra
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pre-mRNA splicing and to produce functional Sxl and Tra 
proteins only in female flies. Then, where does the initial 
functional Sxl protein come from in the female but not in 
the male flies? Keyes et al. (1992) showed that the Sxl gene 
actually has two promoters, Pe (for embryonic or 
establishment promoter) and Pm (for maintenance promoter).
Pe is located within the intron of the Sxl-Pm transcription 
unit (Keyes et al., 1992). Pe is active in early embryos of 
the 2X/2A female but not in those of the 1X/2A male flies.
In addition, the transcripts produced from Pe are spliced 
directly from the embryonic exon 1 to exon 4, skipping exons 
2 and 3 (exon 3 has a stop codon, Fig, 9). Except the N- 
terminal 25 aminal acids, the early transcripts encode 
proteins identical to the late female transcripts. These 
embryonic Sxl proteins direct the female-specific splicing 
of the first transcripts expressed from the late, Sxl 
maintenance promoter (Estes et al. 1995).
There are several mechanisms that may have produced a 
gene with multiple promoters during evolution. First, a gene 
may acquire a second promoter via transposable elements or 
retroviral integration. For example, promoter insertion via 
retroviral integration has been shown to be responsible for 
the activation of cellular oncogenes (Hayward et al, 1981). 
Second, an additional promoter may be created by inversion 
of DNA sequence. It has been shown that the Antennapedia 
{Antp) phenotype (conversion of antennae into legs) in 
Drosophila resulted from a promoter insertion via inversion
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(Fisher et al., 1986). Upstream of Antp (locus 84B) there is 
a transcription unit belonging to locus 84C, which is active 
in the head. Structural analysis of the mutant allele of 
Antp revealed an inversion of a DNA stretch of the 84C 
promoter. As a consequence, Antp transcription is brought 
under control of the head-specific 84C promoter, leading to 
Antp expression in the head. Another way to create tandem 
promoters may be the duplication of a promoter followed by 
diversification. Such example has been reported for the gene 
encoding pancratic amylase in mouse strain CE (Bodary et 
al., 1985). Finally, multiple promoters may also be created 
by deletion. For example, in Drosophila melanogaster, the 
ADH gene contains a single gene with two promoters. In D. 
muelleri, however, there are two functional ADH genes in 
tandem, each with one promoter (Fischer and Maniatis, 1986).
The D. melanogaster ADH gene and its two promoters may be 
produced by the deletion of the coding region of the 
upstream gene.
Having multiple promoters is sometimes not conserved 
among different species. For example, the human aldolase A 
gene has three promoters. However, there is no mouse 
counterpart for the most upstream promoter of the human 
gene, although homology exists in the coding regions for the 
human and mouse genes (Stauffer et al., 1990; Gautron et 
al., 1991). In rat, the aldolase A gene also lacks the most 
upstream promoter (Mukai et al., 1991). The most upstream 
promoter of the human gene may be acquired in human or
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deleted in mouse and rat after humans and rodents 
diversified.
The regulation of a gene is more complex when the gene 
has multiple promoters. One aspect of this complexity is 
that the multiple promoters share an enhancer. In other 
words, the same enhancer activates the transcription from 
more than one promoters. For example, the most upstream, 
constitutive promoter of the human aldolase A gene shares a 
muscle-specifc enhancer with the muscle-specific promoter in 
the muscle cells, but shares a ubiquitous enhancer with the 
most downstream, constitutive promoter in other cells 
(Concordet et al., 1993). On the other hand, having multiple 
promoters might result in one promoter interfering with the 
expression of the other promoter(s). The Drosophila 
melanogaster ADH gene is such an example. As mentioned 
above, this gene has two promoters. The proximal promoter 
transcribes the gene primarily in first to early third- 
instar larvae, while the upstream promoter is active in late 
third-instar larvae and adults (Corbin and Maniatis, 1989).
Each promoter has its own enhancer, but the ADH larvae 
enhancer and the proximal promoter are seperated by the ADH 
adult enhancer and the distal promoter. When the distal 
promoter is active, the proximal promoter is shut off. If 
the distal promoter is deleted, the proximal promoter is 
active in first instar larvae to adults. Therefore, the 
developmental switch from the proximal to distal promoter is 
regulated by the stage-specific activation of the distal
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promoter, and the subsequent repression of the proximal 
promoter by transcriptional interference (Corbin and 
Maniatis, 1989).
Another example of promoter switch during development is 
the human fetal (y-)-to-adult (fl-> globin gene swtich. I
include this mammalian example here, although the two 
promoters transcribe not the same, but two closely linked 
genes. When either the human y- or fi-globin gene is linked 
seperately to the (5-globin gene locus activation region 
(LAR), both genes ca be expressed in transgenic mice 
throughout development. However, when both genes are linked 
to the same LAR, the normal developmental switch of the 
human globin gene expression is reproduced in the transgenic 
mice (Enver et al., 1990), Therefore, the human fetal-to- 
adult globin switch is controlled through a mutually 
exclusive interaction between LAR and either the y- or (1-
globin gene, resulting in the expression of only one of 
these two gene at any given moment (Enver et al., 1990). 
Although the detailed mechanism of this mutually exclusive 
expression of only one of these globin genes is not clear, 
several adult stage-specifc transcription factors (NF-E4 and 
bCTF) have been shown to interact with the promoter region 
of the adult gene to subsequently activate this gene and 
indirectly repress the expression of the fetal globin gene 
(Foley and Engel, 1992). Another factor is human Erythroid 
Kruppel-like factor (EKLF), containing zinc finger domains 
similar to the Kruppel protein of Drosophila melanogaster.
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This protein has been shown to bind to the CACCC element in 
human (J-globin gene promoter and activate the transcription 
of the (5-globin gene (Dome et al., 1995) . This factor 
activates the adult gene 1000-fold, while it activates the 
fetal gene only 3-fold. This is because the EKLF protein 
binds to the CACCC box of the adult gene 8-fold more 
efficiently than to that of the fetal gene. In addition, 
this factor is expressed at a 3-fold higher level in adult 
erythroid tissue than in fetal erythroid tissue (Donze et 
al., 1995) .
OBJECTIVES AND RATIONALE
In this dissertation research, I have set forth three 
objectives:
The first object! vs of this study is to 
characterise the 5' ends of the mRNAs of the 
rnFFK gene.
The rabbit muscle PFK gene (Lee et al,, 1987) and then 
its two cDNAs (Li et al., 1990) were previously cloned. Yet, 
whether the two cDNAs are derived from two separate 
promoters or from one promoter and alternative splicing 
remains elusive. To further study the regulation of this 
gene, it is important to characterize the 5'-ends of its 
mRNAs and the transcription start sites.
Three methods will be used to accomplish this goal: (1)
anchored polymerase chain reaction (PCR) to directly clone 
and sequence the 5'-end of the rmPFK mRNA; (2) primer 
extension; (3) SI mapping.
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There are advantages and drawbacks for each method. In 
primer extension and anchored PCR, secondary structure in 
the RNA template might cause reverse transcription to be 
prematurely terminated. In this case, the end of the cDNA 
extended from the primer would be shorter than the actual 5' 
end of the mRNA, SI mapping and RNase protection assays are 
similar in principle: a labeled DNA or RNA probe is 
hybridized to the mRNA, and the 3' overhang of the probe is 
digested by SI nuclease or RNase, while the double stranded 
mRNA-probe is protected from SI or RNase digestion. The size 
of the protected probe will indicate the 5'-end of the mRNA 
that hybridized to the probe. However, if there is an intron 
spliced out in the mRNA but not in the probe, the splicing 
junction instead of the 5' end of the mRNA will be mapped.
Since there are intrinsic problems with each method, 
combinations of two or three of the methods will be used to 
map the 5' end of the mRNA.
Tho second objectivo is to etudy the tiseue- 
•pecificities of the different rmPVK mRNAa.
As mentioned above, the rabbit muscle PFK is highly 
expressed at the protein level in skeletal muscle, brain, 
heart, kidney, but at very low levels in liver. Since there 
are at least two rmPFK mRNAs, it is important to understand 
the tissue-specificities of different rmPFK mRNAs. Northern 
blot analysis and reverse-transcription (RT)-PCR wil1 be 
employed to accomplish this objective. Both methods are 
frequently used in studying gene expression at the mRNA
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level. The sensitivity of the latter method is higher than 
that of the former. In addition, the RT-PCR will detect 
alternatively spliced mRNAs.
The third objective is to optiaise conditions for 
priaer extension using s theraostable DMA 
polyaerase.
During the course of the study, I found that the 
secondary structure in the rmPFK mRNAs causes the reverse 
transcription to prematurely terminate in primer extension 
and anchored PCR. Higher temperatures of the reverse 
transcription reaction destabilize the secondary structure 
and hence minimize the problem. Conventional reverse 
transcriptase, such as M-MLV reverse transcriptase or AMV 
reverse transcriptase, can only tolerate a temperature up to 
50°C. At 50°C, the secondary structures in the rmPFK still 
cause problems. Meyers and Gelfand (1991) reported that a 
94-KDa DNA polymerase from Thermus thermophilus possesses 
reverse transcriptase activity at temperatures as high as 
75°C. However, the reverse transcription reaction is not 
efficient enough for primer extension analysis. I therefore 
will optimize the experimental parameters for the reverse 
transcription reaction using this thermostable enzyme 
(Section II) .
This improved method will be used in the reverse 
transcription reactions in the primer extension and anchored 
PCR experiments characterizing the rmPFK mRNAs described in 
SECTION I of this dissertation.
SECTION I
TISSUE-SPECIFIC EXPRESSION OF SIX TYPES OF RABBIT 
MUSCLE PHOSPHOFRUCTOKINASE mRNAS BY MULTIPLE 
PROMOTERS AND ALTERNATIVE SPLICING
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INTRODUCTION
Phosphofructokinase (ATP:Fructose-6-phosphate 1-phospho- 
tranferase, EC 2.7.1.11, PFK) catalyzes the phosphorylation 
of fructose 6-phosphate to produce fructose 1,6- 
bisphosphate, the rate-limiting step in glycolysis. PFK 
controls glycolytic flux through its allosteric responses to 
cellular metabolites. For example, mammalian PFK is 
inhibited by high concentration of ATP and citrate. On the 
other hand, it is activated by ADP, AMP, F-l,6-BP, and F-
2,6-BP (reviewed in Dunaway, 1983; Uyeda, 1979). in 
mammalian tissues, PFK can exist as homo- or hetero- 
tetramers of three types of subunits: M (muscle) type, L 
(liver) type, and C for a third type of subunit in brain.
For example, in human, rabbit, and rat, the M type PFK is 
the predominant isozyme in skeletal muscle, while the L type 
is the most abundant form in liver. In heart, brain, and 
kidney, PFK exists as homo- or hetero-tetramers of all three 
subunits (Tsai and Kemp, 1973; Dunaway and Kasten, 1987; 
Dunaway et al., 1988). The homo-tetramers of M, L, and C 
type subunits of the rabbit PFK have been shown to possess 
different kinetic properties (Foe and Kemp, 1985) . Among the 
three rabbit isozymes, the M PFK is the least sentitive 
isozyme to ATP inhibition, while the L PFK is the most 
sensitive one. To activation by Pi, AMP, ADP, and F-2,6-BP, 
the M isozyme is the most sensitive one, while the C isozyme 
is the least sensitive one (Foe and Kemp, 1985). The
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relative levels of these three isozymes in a given tissue 
determine the composition of PFK tetramers and subsequently 
their allosteric behavior in that tissue (Dunaway and 
Kasten, 1987; Dunaway et ai., 1988). Thus the molecular 
basis for the regulation of the rate of glycolytic flux lies 
in the control of the tissue-specific expression of the 
genes encoding the three types of PFK subunits.
To study the regulation of tissue-specific expression of 
the mammalian PFK gene, the gene for rabbit muscle PFK was 
cloned (Lee et al., 1987). More recently, two cDNAs of this 
gene with different 5* untranslated regions (UTRs) were 
cloned. The 5’ UTR of one cDNA has an intron spliced out (Li 
et al., 1990). In this study, more cDNAs for the 5' UTRs of 
the rmPFK gene were cloned using anchored polymerase 
chain reaction (PCR) (Loh et al., 1989) and reverse 
transcription-PCR (RT-PCR) (Meyers and Gelfand, 1991) . The 
cloning results indicate that there are six types of rmPFK 
mRNAs that differ in the 5' UTR. These rmPFK mRNAs are shown 
to be expressed in tissue-specific manners by at least three 
promoters and by alternative splicing. Further the 
transcription start sites of two promoters of this gene have 
been determined. Altogether, the results of this study 
indicate that the rabbit muscle PFK gene expresses its six 
mRNAs tissue-specifically by multiple promoters and 
alternative splicing.
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MATERIALS AMD METHODS
Victors, bacterial strains, and ansyMas
Restriction endonucleases, DNA ligase, and DNA kinase 
were obtained from GIBCO-BRL Co., New England Biolabs, or 
Boehringer Mannheim Corp. M-MLV reverse transcriptase 
(Superscript) was purchased from GIBCO-BRL Co. Tag and Tth 
DNA polymerases were purchased from Perkin Elmer Cetus Corp. 
SI nuclease was purchased from Promega. Bluescript II KS( + ) 
plasmid, helper phage and the XLl-Blue strain of E. coll 
were from Stratagene. The Sequenase® kit and terminal 
deoxynucleotidy1 transferase were purchased from United 
States Biochemical Corp. Nucleotides labeled with 32P or 35S 
were obtained from duPont-NEN or ICN Biochemicals. 
Oligonuclnotidns used in this study
The oligodeoxyribonucleotides (oligos) used in this study 
(listed in Table 2) include: (1) primers used in anchored
PCR; (2) probes used in Northern blot analysis; (3) primers 
used in RT-PCR studies; and (4) primers used in primer 
extension studies. The oligos for the rabbit muscle PFK gene 
are named from A to 0. The lowercase x in the name denotes 
an Xbal restriction site at the 5' end of the primer. The 
oligos were synthesized in house and purified from 
polyacrylamide-urea gel (Sambrook et al., 1989). Oligo(dT)- 
cellulose (Type III) was purchased from Collaborative 
Research, Inc.
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Table 2. Oligonucleotides used in this study
Oligonu­
cleotide Sequence {5* -- > 3')
Position*
Ax GATCCACIC2AS&AGGCAAGACGATGGTCAGTTAGG -36, H
Bx GATCTA GA CCT AAT A CCTTG TG T GGGA -1715, M
C GGCTGCATGGTGCTCTTCATGGGTC +3, M
Cx GGATCCTCTAGAGGC TGCA TG GTG CTCTTCA TG GG TC +3, M
Dx GGGCTCTAGAGCCCCCCCCCCCCCCC
E CACCGCGATGGCCTTGCCGACCCCCAGGGT +31, H
F AAGGCAAGACGATGGTCAGTTAGGACACA -41, M
G GTGTGGGACTTGAACTGCTTCTTATGCAC -1736, H
H CTCTGTGGCCTTTCGCAGGAGTCTG -1973, M
I GTCCTGCAATCCATGCGTGTGAACA -2570, M
J GCCGCGCTCGCCTCAGTCCCAGCTT -2045, M
K CTAACTGACCATCGTCTTGCCTT -13, P
L CAGACTCCTGCGAAAGGCCACAGAG -1949, P
H gggtctctgttcacacgcatggatt -2554, P
N CTGGGAC TGAGGC GAGCGCGGCC TT -2010, P
0 CTGCCATCACCGCCTATCACACA +340, M
GAFDH1 CATGTAGACCATGTAGTGGAGGTCAATG M
GAPDH2 GATCCATTCATTGACCTCCACTACA P
GAPDH3 GATCTCGCTCCTGGAAGATGGTGAT M
The lower case x in the name of the oiligo 
represents an Xbal restriction site at the 5* end. 
This Xbal restriction site is underlined in the 
sequence of primer Ax, Bx, Cx, or Dx. Oligo C and Cx 
are essentially the same, except that Cx has an Xbal 
site at the 5* end.
*: The number is the position of the nucleotide at 
the 3' end of each rmPFK primer or probe relative to 
the ATG start codon, with A being +1. P or M 
following the position indicates the oligo is 
located on the plus or minus strand, respectively.
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Preparation of poly(A)+ RHAs
Total RNAs from skeletal muscle, liver, kidney, heart, 
and brain of 10 day-old New Zealand white rabbits were 
extracted by homogenizing the tissue in guanidinium 
isothiocyanate, followed by cesium chloride gradient 
centrifugation (Chirgwin et al., 1979). Poly(A)+ RNA was 
purified from total RNA by oligo(dT) cellulose column 
chromatography (Sambrook et al., 1989). The concentration of 
poly(A)+ RNA was determined by measuring the absorbance at 
260 nm (A260) •
Anehorod PCR
Anchored PCR (Fig. 10) was performed as described (Loh et
al., 1989) with the modifications given below.
Reverse transcription
Poly (A)+ RNA (8 )lg) was co-precipitated with 25 ng of 
primer C or E (Fig. 10), dissolved in 20 )il of buffer (80 mM 
Tris, pH 8.3; 80 mM KC1), heated at 90°C for 2 min., and 
allowed to anneal at 52°C for 3 hr. After annealing, 30 .^1 
of reverse transcription mixture (20 mM DTT; 0.1 mg/ml
bovine serum albumin [8SA]; 0.5 mM each of dATP, dGTF, dCTP,
and dTTP; and 20 units of RNAsin [Promega]) was added to the 
annealing mixture. Reverse transcription was carried out in 
the presence of 0.03 ^Ci of [a-35S]dATP and 200 units of M-
MLV reverse transcriptase (Ausubel et al., 1993) at 42°C for 
1 hr.
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Figure 10. Strategy of anchored PCR used to clone the 5* 
UTRs of different rmPFK mRNAs. (A) Schematic of the genomic 
DNA contains the 5' flanking region and the first coding 
exon of the rmPFK gene. (B) Diagram depicting the scheme of 
anchored PCR to clone the 5’ portion of rmPFK cDNAs that 
contain the 5' UTRs of cDNA-A and cDNA-B (Li et al., 1990). 
Primer C was annealed to rabbit poly(A) RNA and extended 
with reverse transcriptase. The cDNAs were tailed with dGs 
with terminal deoxynucleotidyl transferase. The tailed 
cDNAs were amplified with primer Ax or Bx and Dx. Primers 
Ax and Bx are specific to the 5* UTRs of cDNA-A and cDNA-B, 
respectively. Primer Dx is an oligo with 15 consecutive dCs 
and a Xbal restriction site at the 5'. The sequences of the 
primers are shown in Table 2. Arrows: primers used in 
anchored PCR; X: Xbal restriction sit; open box: 5* UTR of 
cDNA-A or cDNA-B; dotted box: the first coding exon. (C) 
Anchored PCR strategy used to clone the 5' UTRs of 
different kinds of mRNAs transcribed by all the alternative 
promoters of the rmPFK gene. In this experiment, reverse 
transcription was carried out using primer E and rabbit 
muscle poly(A) RNA. The oligo dG tailed cDNA products were 
applified with primers Cx and Dx. Primer Cx is primer C 
with a Xbal site at the 5* end. Open box with broken end;
5' UTR of all kinds mRNAs of the rmPFK gene.
TATA
J_
B
Dx
c
ssr
I cDNA-B
1 cONA-A
« any rmPFK 
mRNA
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Tailing the 3* ends of cDNAs with dGs hv terminal 
deoxynucleotidvl transferase
The unincorparated deoxynucleoside triphosphates 
remaining from the previous step were removed 
using a Sephadex G-50 column (5 Prime to 3 Prime Co.). 
Fractions included in the first radioactive 
peak were pooled and precipitated with 2.5 volumes 
of ethanol in the presence of 0.3 M sodium acetate.
The purified DNA-RNA duplex was dissolved in the tailing 
buffer (0.1 M sodium cacodylate, pH 7.1; 2 mM MnCl2; 0.1 mM
DTT; 80 *iM dGTP; 0.05 mg/ml BSA) (Deng and Wu, 1983). The 
dGTP polymerization reaction was carried out by the 
addition of 34 units of terminal deoxynucleotidyl 
transferase and incubation at 30°C for 1 hr.
The products were precipitated once with ethanol 
and redissolved in 20 )il of TE (10 mm Tris, pH 7.6;
1 mm EDTA).
PCR amplification
One third of the DNA products generated from the tailing 
process was amplified by PCR (Saiki et al., 1988) using an 
rmPFK specific primer and primer Dx containing 15 C's and a 
Xbal site at the 5' end (Fig. 10; for sequence see Table 2). 
The conditions for denaturation, annealing and 
polymerization were 95, 55 and 72°C for 1.5, 1 and 2 min, 
respectively. The amplifications were carried out for 30 
cycles.
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Cloning and sequencing of the PCR products
These PCR products were inserted into the Xbal site of 
Bluescript plasmid which was subsequently transformed into 
the XLl-Blue strain of E, coli. Single-stranded DNA 
templates were prepared by coinfecting the cells with VCS- 
M13 helper phage according to the manufacturer's 
instructions. DNAs were sequenced by the dideoxynucleotide 
chain termination method (Sanger et al., 1977) using 
Sequenase kit (USB).
31 mapping
SI mapping was carried out as described (Ausubel et al., 
1993). Briefly, the 5' labeled oligo F or G (Table 2) was 
annealed to the single-stranded DNA of plasmid RMPFK5', This 
plasmid was constructed by inserting the 5' flanking region 
of the rmPFK gene into the SstI site of pBluescript vector. 
The annealed oligo was extendede using Sequenase (USB). The 
single stranded probes were purified from an alkaline 
agarose gel. 2X105 CPM (0.2 pmole) of each probe was 
hybridized with 8 Jig poly (A)+ RNA in the aqueous
hybridization buffer overnight at 50°C. SI nuclease (150 
units per 300 jjtl reaction) digestion was carried out at 30°C
for 1 hr. Final products were analyzed on a sequencing gel. 
The size marker is the sequencing ladder using oligo F or G 
as primer, and plasmid RMPFK5' as template, both of which 
are used to generate the single-stranded SI mapping probe.
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Frinwr extension
Primer extension was performed as described (Ausubel et 
al., 1993) with 8 Jig poly (A) + RNA from rabbit muscle and 
2xl05 CPM (0.2 pmole) of 5' end labeled primer. Reaction 
products were resolved on 6% polyacrylamide gels containing 
8 M urea.
Primer extension and anchored PCR using thermostable 
Tth DNA Polymerase
Primer extension by Tth DNA polymerase was carried
out as described below. The hybridization mixture
(12 uD containing 16.7 mM Tris-HCl (pH 8.3),
150 mM KC1, 2xl05 CPM (0.2 pmole) of primer B and
8 (ig of rabbit poly(A)+ RNA was heated at 75°C for
5 minutes to denature the RNA. After annealing at 65°C 
for 5 minutes, extension mixture (8 111) containing 
2.5 mM Mnci2, 500 JIM each of dATP, dGTP, dCTP, and dTTP,
and 5 units of Tth DNA polymerase was added to 
the hybridization mixture. 20 (11 of mineral oil was
overlaid on top of the reaction mixture. Primer extension 
was carried out at 65°C for 1 hour. All the incubations 
were carried out in a Perkin Elmer Cetus thermocycler.
After the extension, the mineral oil was carefully removed 
and residual oil was further depleted by phenol/chloroform 
extract ion.
Along with 20 (ll of H2O, 105 (11 of RNase reaction mixture 
(100 (ig/ml salmon sperm DNA, 20 (ig/ml DNase-free RNase A,
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Ausubel et al., 1993) were added to each of the primer 
extension reaction tubes. RNase digestion was carried 
out at 37°C for 15 minutes. The mixture was extracted with 
phenol/chloroform/isoamyl alcohol and precipitated and 
analyzed as described (Ausubel et al., 1993)
Anchored PCR using Tth DNA polymerase was carried out as 
described above using Superscript reverse transcriptase, 
except that Tth DNA polymerase instead of the Superscript 
reverse transcriptase was used during the reverse 
transcription step. 
northern blot hybridisation
Northern blot hybridization was carried out as described 
(Sambrook et al., 1989). Briefly, 8 jig of poly(A)+ RNA from 
each rabbit tissue was fractionated on a formaldehyde 
denaturing agarose gel (1%) with 1 X MOPS buffer (20 mM 
MOPS, pH 7,0; 8 mM NaOAc; 1 mM EDTA). The RNAs were blotted 
overnight onto Nytran membrane (0.45 Jim) . Oligonucleotide 
probes were end-labeled using T4 polynucleotide kinase and 
[y-3JP]ATP (Sambrook et al., 1989). Filters were
prehybridized in hybridization solution (6 X SSPE; 10 X 
Denhardt's; 50 Jig/ml tRNA; 0.1% SDS; 0.05% NP-40) at 55°C 
for 2 hrs and for an additional 20-22 hrs after adding end- 
labeled probes <2 X 106 CPM/ml, 106 CPM/pmole). Hybridization 
was carried out in an Autoblot Micro Hybridization Oven 
(Bellco Glass).
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Analysis of tbs six rsFTK mRNA sxprsssion in rabbit 
tissuss by RT-PCR tschniqus
rt-PCR was performed as described (Meyers and Gelfand, 
1991), except that the reverse transcription reaction was 
carried out at 65°C for 10 min instead of at 70°C for 5 min. 
RESULTS
Cloning and aaquancing of cDNAs for tbs 5' UTRs of 
tbs rmPTK mRNAs by ancborsd PCR
Li et ai. (1990) previously cloned two cDNAs of the 
rmPFK gene with divergent 5' UTRs but with identical coding 
regions. Alignment of the sequences of these 5' UTRs with 
the 5' flanking genomic sequence of the rmPFK gene 
revealed that cDNA-A has a 1.69 kb intron removed by 
splicing in the 5' UTR (Fig. 10B; Li et al., 1990). 
Theoretically, cDNA-A and cDNA-B could be derived from two 
different promoters or from one promoter by alternative 
splicing. If they result from alternative splicing, the 
mRNAs should share a common 5' exon. In order to clone 
and sequence the 5' exons of the rmPFK mRNAs, anchored PCR 
(Loh et al., 1989) was used.
The anchored PCR is described in detail in MATERIALS 
AND METHODS and outlined in Fig. 10 in this SECTION. When 
primer Ax (Fig. 10B) was used, six clones were sequenced. 
Among them, three clones are identical and are therefore 
interpreted as one cDNA (designated as cDNA-1). The sequence 
of this cDNA is shown in Figure 11. The 5' end of this cDNA 
is located at -86 (The A of the ATG translation initiation
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cD N A -1 AGTCTGACGAAGCTGTCGCTTGAGCTAGCGGCACCTTGACCCAGCTGTGTCCTAACTGACCATCG
TCTTGCCTTCTAGAGTGGATCATaACCCATGAAGAGCACCATGCAGCC- 3 '
cD N A -2 AATCTAGTCCAAACCCTTCTTAGTGCATAAGAAGCAGTTCAAGTCCCACACAAGGTATTAG|AGT
GGATGAXQACCCATGAAGAGCACCATGCAGCC- 3■
cD N A -3 GAGAGCGGGGAGAAGCTGGGACTGAGGCGAGCGCGGCCTTCG|CTCTCCGGAGGTATAAAACGTG
AGAGGGGCAGGCTGCTGAC CCCCAATCTAGTCCAAACCCTT CTTAGT GCATAAGAAGCAGTTCAA 
GTCCCACACAAGGTATTAG|AGTGGATCATGACCCATGAAGAGCACCATGCAGCC- 3 ’
cD N A -4 GAGAGCGGGGAGAAGCTGGGACTGAGGCGAGCGCGGCCTTCG|AGTGGATCATQACCCATGAAGA
GCACCATGCAGCC- 3 •
cD N A -5 TGCCAGCTTTTAGTAGCCCTCCCGTCCTCGGGGTCATCTGTCCAGTGGTCGGCAGACTCCTGCGA
a a g g c c a c a g a g c a a g t g t g t g a g g c t t t g t g g g g t g g a c g a t c t c t t g c a g t a c c t g t t c t g c c
GCCGTAGCACAGCGCAGCCATGAATCCTGTGTGAATGGAGGTGTAAGGATGGTCTCTGAATCTGA
a t t t c c t c t g t t c t t c a c c t g t c a c a g c t c t c c g g a g g t a t a a a a c g t g a g a g g g g c a g g c t g c t
GAC CCCCAATCTAGTCCAAACCCTTCTTAGTGCATAAGAAGCAGTTCAAGTCCCACACAAGGTAT 
TAG|AGTGGATCATOACCCATGAAGAGCACCATGCAGCC-3>
eO N A -6 GOGCACATGCGTGGGTCTCTGTTCACAOGCATGGATTGCAGGACCTGTGTTTATCCGCATGT|CT
CTCCGGAGGZAIUUCGTGAGAGGGGCAGGCTGCTGACCCCCAATCTAGTCCAAACCCTTCTTA 
GTGCATAAGAAGCAGTTCAAGTCCCACACAAGGTATTAG-3 ’
cD N A -7 GCAGACTCCTGCGAAAGGCCACAGAGCAA|CTCTCCGGAGGTATAAAACGTGAGAGGGGCAGGCT
GCTGACCCCCAATCTAGTCCAAACCCTTCTTAGTGCATAAGAAGCAGTTCAAGTCCCACACAAGG 
TATTAG|AGTGGATCATQACCCATGAAGAGCACCATGCAGCC-3 ’
Figure 11. Sequences of rmPFK cDNAs cloned by anchored PCR 
and RT-PCR. The ATG tranlational start codon is in bold. 
The TATAAAA sequence is underlined. Proposed splice 
junctions are indicated by vertical lines.
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codon is designated as +1). This cDNA is diagramed in Fig. 
12. The 5' ends of the other three clones (sequence not 
shown) are 10 bp or less downstream of cDNA-1. With primer 
Bx, six clones were sequenced. Among them, five clones are 
identical in sequence and are also considered as one cDNA 
(designated cDNA-2, Fig. 11 for sequence). The 5' end of 
cDNA-2 is located at -1758. The sixth clone is 5 bp shorter 
than cDNA-2 (not shown). The 5' end of cDNA-2 is 45 bp 
shorter than that of cDNA-A of Li et al. (1990). SI mapping 
results (described later, Fig. 17) indicate that cDNA-2 
resulted from premature termination of the reverse 
transcription, probably due to a strong secondary structure 
in the rmPFK mRNA template. Using a thermostable reverse 
transcriptase, several cDNAs containing the entire 5' UTR of 
cDNA-2 were cloned (see below). Therefore, cDNA-2 is not 
considered a full length cDNA of a rmPFK mRNA and is hence 
not diagramed in Fig. 12.
In order to identify other possible rmPFK mRNA whose 5* 
UTR is not complementary to either primers Ax or Bx, a 
different strategy was utilized (Fig. 10C). Primer E, which 
is downstream of primer C, was used to perform the reverse 
transcription. The dG-tailed cDNA products were then 
amplified by PCR using primer Cx and primer Dx. Primer Cx is 
complementary to the first 9 codons of the rmPFK open 
reading frame, while primer Dx is an oligo of 15 dCs with a 
Xbal site (Fig. 10C). In theory, any mRNA containing the
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Figure 12. Schematic diagram depicting the organization of 
the S' portion of the rmPFK gene and the six mRNAs 
identified by anchored PCR and RT-PCR . (A).organization of 
the rmPFK gene. Boxes numbered IA, IB, IC, ID, and IE 
represents the exons in the 5' UTRs of the gene. Exon I is 
the first coding exon. There is no splicing event between 
exon IA and exon II. Only shown are the exons in the 5' UTR 
and the first 5 coding exons. Bent arrows indicate 
transcription start sites. Only start sites a and b have 
been established. The bent arrow in front of exon ID and IE 
are putative promoters, their transcription start sites 
have not been mapped. The positions of the oligo probes 
used in the Northern blot are shown under each exon. The 
sequences of these probes are shown in Table 2. TATA: the 
TATAAAA sequence found in cDNA-A (Fig. 10; Li et al.,
1990); ATG: initiation codon. <B) Schematic diagram 
depicting the six cDNAs identified by either anchored PCR 
(cDNA-1, -3, -4, -5, and -6) or RT-PCR (cDNA-7), Downward 
bent solid line: intron with known sequence. The primers 
used in the RT-PCR experiments are shown on top or below 
the cDNA. Oligo 0 represents the 3' primer and is 
complementary to the fifth coding exon. The sequences of 
the primers are shown in Table 2.
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first coding exon of the rmPFK gene should be cloned by this 
strategy. Sequence analysis of eighteen clones containing 
anchored PCR products (not shown) confirmed the 5' UTRs of 
cDNA-1 and cDNA-2 (Figure 11) cloned using Oligo Ax or Bx as 
downstream primer and Dx as upstream primer. These results 
also showed the splicing of exon IB onto exon I as in cDNA-A 
of Li et al. (1990).
In addition, two cDNAs with unique 5' UTRs were 
identified. The first one is designated cDNA-3 (Fig. 11), 
which has an extra 5' exon (exon IE) spliced onto the 5' end 
of exon IB (diagramed in Fig. 12). Comparison between the 
sequence of this cDNA and the genomic sequence of the rmPFK 
gene indicates that another intron of 1011 bp is removed by 
splicing in the 5' UTR of this cDNA, in addition to the 
spliced intron in cDNA-A of Li et al, (1990). The second
clone (cDNA-4, see Fig. 11 for sequence and Fig. 12 for 
diagram) is a splicing variant of cDNA-3; exon IB is not 
retained in cDNA-4 (Fig, 12).
Cloning of cDNAs for the 5' UTRs of raPFK mRNAs by 
anchored PCR using thermostable reverse 
transcriptase rTth DMA polymerase
In an effort to determine the transcription start sites 
of this gene, SI mapping results (described later in this 
section, Fig. 17) suggest that the 5' end of cDNA-2 results 
from premature termination of reverse transcript ion during 
the anchored PCR, This premature termination is probably due
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to a strong secondary structure in the 5' portion of rmPFK 
mRNA (Fig. 17). Therefore, anchored PCR experiments were 
carried out using thermostable Tth DNA polymerase in the 
reverse transcription step at high temperature (65°C). The 
possible secondary structure in the rmPFK RNA should be 
destabilized at 65°C. Using primer C in reverse trancription 
and primers Bx and Dx in PCR (Fig. 10B), this experiment 
identified three groups of cDNAs that contain exon IB. The 
first group (four clones) is designated cDNA-5, with the 5' 
end of the longest clone located at -2857 (Fig. 11 for 
sequence and 12 for diagram). The second group (one clone) 
is a new type (designated cDNA-6), with an exon of 63 bp 
(exon ID) spliced to exon IB (Fig, 11). Alignment of the 
sequences of exon ID and exon IB with that of the rmPFK 
genomic DNA indicates that an intron of 705 bp is removed by 
splicing (Fig. 12), The 5' end of this cDNA is located at 
-2591. The third group (eight clones) is the same as the 
afore mentioned cDNA-3 (Figs. 11 and 12). No clone matches 
cDNA-2, which is probably derived from prematurely 
terminated reverse transcription of the anchored PCR. This 
is consistent with the SI mapping results (see later, Fig. 
17). Therefore, cDNA-2 is not considered representing a 
rmPFK mRNA.
To summarize, these three anchored PCR experiments 
identified a total of five rmPFK cDNAs (Figs. 11 and 12), 
excluding cDNA-2, An additional cDNA, designated cDNA-7, was
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identified by RT-PCR (see below). The exon sequences of the
5' UTRs of these six rmPFK cDNAs and the genomic sequences
are aligned and shown in Figure 13.
Tissue specific expression of rnPFK mRNAs 
contsiningdifferent 5' exons ss analysed by 
Northern blot analysis
After the cloning of the cDNAs for the rmPFK mRNAs, 
the tissue-specific expression patterns of these mRNAs 
were examined by Northern blot analysis using 
oligonucleotide probes complementary to the 5' exons 
of the rmPFK mRNAs. The positions of the probes are 
shown in Figure 12 and their sequences are shown in 
Table 2, All the probes detected a single mRNA 
aproximately 3 kb in length (Fig. 14). The transcript of 
the human muscle PFK gene is also about 3 kb (Sharma et al., 
1990).
The expression of four rmPFK mRNAs are detected by 
Northern blot only in skeletal muscle (Fig. 4). Oligo probe 
F specific to mRNA-a detected the expression of this mRNA 
only in skeletal muscle (Fig. 14). Oligo probe H 
complementary to both mRNA-bl and mRNA-b2 detected these 
mRNAs also only in skeletal muscle (Fig. 14), Finally, 
Northern blot using oligo probe I showed that mRNA-c is also 
skeletal muscle specific (Fig. 14),
Using oligo probe J specific to exon IE, the expression 
of exon IE was detected in all five tissues examined (Fig. 
14). Both mRNA-dl and mRNA-d2 contain exon IE and they are
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Figure 13. Sequences of the 5' flanking region of the rmPFK 
gene. The A residue of the ATG (bold phase and underlined) 
translational initiation codon is designated +1. Sequences 
of exons are in capital letters and underlined. The gap in 
the sequence between exon IA and exon I was created to 
indicate the boundary of the two exons, so the sequence is 
continuous. The TATAAAA sequence found in cDNAs containing 
exon IB is italic and in bold face.
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-3017 ttagctc
-3010 actgctcactcattaggcaccccaggctttacactttatgcttccggctcgtatgttgtgtggaattgtg 
-2940 agcggataattgtgagcggataacaatttcacacaggaaacagctatgacatgattaegaattegagctc 
-2970 <wt«ff^fann^fnaftAWfaMMafiaaflrrflnaarTflaQOCGfcGCGgfSQCCTTCGgggaaeattaocgaQa
Exon IE
-2 9 0 0 gctgggaggccgagagcctggagggcggccgt gcggggcgggcgga a t cta tagagegcea cagagcggg 
-2730 ggccgcgcagagggaeeeecgccgcctccctccttgegtcgcaccgcetcatcctgcggccgggtttggc
-2990 gggaggegetggggccacgtegecceeeaccggcagccaaacctggcccgggcccagtggetccgcaccX
-2590 QCGCACATGCGTGGGTCTCTGTTCAGACGCATGGATTGCAGGACCTGTQTTTATCGQCATGTnfcooat fc.o
Exon ID
-2520 cgggaccggtgtgtgtgcgcatgagtgggtggtgggcecatgtgtgtcctegtgtgtgcatcgctateac 
-2450 acacgtgggctgaggcettctgcgtggggtctgcagtgttcgtgcgtcgcgaaatcccgtccggagctcc 
-2390 ttgctaggatttctcctccgtgagaacgctgggcttcegeggatgacctccegtcettgggaeaggaacc 
-2310 ttgtgattttcctccagcaatgaggagaagaaacggggccggggggtccgagtggtgagatgccttgctc 
-2240 ctccctgtttgctccaagtcctcccacttagcttetgcgcgttctctgtgcctttgtggtttgtcactgt 
-2170 gcttgcttcggtctcagtgcatttttagaagtggaatgcaaggggtatatctgtgeccaggcctgtttta 
-2100 aatttcacctacttgatgtttgetaettgcattgcactttctgtggttatttattggctgtaatgtgcca 
-2030 aaaeeTQCCAaCTTTTXGTXGgggTrrrGTCrTCGQOGTrXTfrTftTCCAGTnf.TGGQCAaxnTCCTflCGE
Exon IC
-I960 AAGGCCACAC.Ar^AAyt pt ?ratoyrr t t-yr aaapr poanaat ct rt r prior mart pt tctoecaccart
-1990 agcacagcgcagceatgaatcctgtgtgaatggaggtgtaaggatggtctctgaatctgaatttcctctg 
-1820 ttct t cieet at e. r .oGTCTCeafiXflfif* * a/vs TVjACAfMQGGAGGgTGgTfSACCCfTGXATC TAGT
Exon IB
-1750 CCAAACCCTTCTTAGTGCATAAGAAOrACTTCAAQTCCCXeAeAAGGTATTAr.otg»«toaraactatnt 
-1690 ggtcecgttgaatgtatgtcagtgttggtttcccaggecaacaggtgtgtctccagcagtgggtgggggt 
-1610 ctgtgegaaggcccagggagccttctggataagagtgcagggcgcctgeaagatgtagggttagagcggg 
-1540 aggageaggttgaagccataggacaggtctggatcatggaggctttgcgagcaaccceagcagttgaact 
-1470 tgatctgtcagtgctgcttctgtgtggtgtgtgegtgttaactgtgtctcctaatgctatgtgtgtgttg 
-1400 tgtgtctcattgeeatgtgtgtggatttgtgtgtcatgtgacctgtatetgagceagtgcetgattgcct 
-1330 agatgtgggtggaagcaegaacttccgteagctectgttcatgtgaggtgatgctgtaactggaagctcg 
-1260 ggcctgaaecttccagaggctgeactgtgcgeagtgggttaagctgcatatcagaaactgeatccatatc 
-1190 tgagtgccagtttgagttctggctgctctgcttgcagtccaetttectgctagtgctcctaggaaggeag 
-1120 cagaagatcgccacgtgcttgggeeectactgtgcgtgtggtagaeetgacgcaattcctggctttggct 
-1050 gttgtggaeatctggggagagtgaaceagtggatggatgacctetctgtttctctgcttctetcattcce 
-980 ccgccaaagtcgctcaaataaataagtgttttttaaaaagagaaagacaggagcccagcaggggagacca 
-910 gctgttacagggagcaggtcaggaagacaggcggtgggggggagaagggagttggggaggacggcactgc 
-840 agggggtggtggggttggtggcagttttggttctgagagaaagggcggagcaagtgaaaaaeagcaggtg 
-770 tttgcctggttgcccggagagtgatgaceccaceagcgttttgagggcaeagaagtetcctgcgctcctt 
-700 tgggagaeagcagcaggagtccctgtgteacgtgtgtgcgtgtgtgcatetgtggcagccacctgttgct 
-630 tttcacatttagttgtgtgcagtgcgagaggcaggggcaggagggttctgggcctggagctgggaggtac 
-560 agggaggtcgaggaatggcccagggcttcctgagectttgaagagtcttggcagtggtgccttcataacc 
-490 ccaaactccagcttgaatcccagctctcccgatgetgctaactgtaacgcagcttgtccttgtttttctg 
-420 ctttgttggtgcttttggggtccagacctetgactgecaccctgtcacegeccttcgctgagaaggagga 
-350 atcttcgaggctcccttgctgtttgctttctgtteagtcatctgcccttcteectgaecttagcttatcc 
-280 tgcagatgggttcctctcggggagggagggactagggagggattagccaggacttttgagtcttgggctt 
-210 gattactgtggcatttcagcttgtcattccacagggtgtggetcteectggaagaagtccagagttccca 
-140 oact oca aage t oaoot ogt ggagt qqgagage ct gee t tj agg* qgt»fr tit » gggAKTrTGAeGAAGeTCT 
-70 CGCTTGAQeTAGCGGCACCTTGACeCAGCTfiTCTeCTAACTGACCATCGTCTTGCCTTCTAG AGTGGATC
Exon IA
1 ATQArrrATRaaf'.aGrarraTGraGrrxr.aacCCTGGGGGTCGGCAAGGCCATCGCGGTGCTCACCTCCG
Exon X
71 GCGGAGATGCCCAAGqtaaqgaqqaqqaqaaeaqqagecatqqctqqtqgecctiqqgttgctigqgtgcct 
121 ttgcctgcacactggagetc
68
probes
M L K H a
m
R H
■ l a i i■ 1 9 S GAPDH1
Figure 14. Northern blot analysis of different rmPFK mRNAs. 
Poly(A)+ RNAs (8 pg) from different rabbit tissues were run 
on a 1% agarose gel with 2.2 M formaldehyde. The nucleic 
acids were blotted to Nytran membranes overnight by 
capillary force. The blot was hybridized with probes 
specific to the exons in the 5' UTRs of the rmPFK gene. The 
position of the probes are shown in Fig. 12 and their 
sequences are in Table 2. M: muscle; L: liver; K; kidney;
H: heart; B: brain. GAPDH1; hybridized with oligo GAPDH1 
(sequence shown in Table 2) complementary to the rabbit 
glyceraldehyde 3-phosphate dehydrogenase cDNA (Putney et 
ai., 1983). Panels hybridized with probes F, G, and J were 
exposed for four days, while those hybridized with probes H 
and I were exposed for seven days. All the blots were 
hybridized at 55°C for 20-22 hrs and subsequently washed at 
55°C two times with IX SSPE and 0.1% SDS and one time with 
1XSSPE. With this stringency, signals detected with probe J 
are unlikely non-specific (also see Fig. 15D for RT-PCR 
results).
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alternative splicing pruducts. Only mRNA-dl is expressed in
all five tissues examined because of the following: Oligo
probe G specific to exon IB, detected rmPFK expression in
skeletal muscle, heart, and brain, but not in liver and
kidney (Fig. 14). Since mRNA-d2 contains this exon,
therefore mRNA-d2 is not expressed in rabbit liver and
kindey tissues. These results and those of RT-PCR (below and
Fig. 15D) indicate that mRNA-d2 is expressed in rabbit
skeletal muscle, heart, and brain, but not in liver and
kidney tissues, where as mRNA-dl is expressed in all five
rabbit tissues examined (Fig, 14 and Fig. 15D). This
indicates that the promoter that produce these two mRNAs is
active in all five tissues, but the alternative splicing is
tissue specific. More specifically, exon IB is retained only
in rabbit skeletal muscle, heart and brain tissues.
A n a l y s i s  o f  t h a  t i s s u e - s p e c i f i c  e x p r e s s i o n  o f  
m u l t i p l e  m R N A s  o f  t h e  r m P F K  g e n e  b y  R e v e r s e  
t r a n s c r i p t i o n  ( R T ) - P C R
The tissue-specific expression patterns of different 
rmPFK mRNAs were further examined by RT-PCR. The primers 
used in this study are shown in Figure 12 (for sequence, see 
Table 2). The common downstream primer (oligo 0) is 
complimentary to the fifth coding exon of the rmPFK gene.
The amplified RT-PCR pruducts include the 5 r UTRs and the 
five coding exons of the rmPFK mRNAs. The presence of a PCR 
product of appropriate size in an agarose gel based upon the
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sequence of the cDNA clones was considered as evidence of 
expression.
Results of the RT-PCR analysis are shown in Figure 15. 
Oligo K, the upstream primer specific to mRNA-a detected 
expression in skeletal muscle and heart tissue (Fig. 15A). 
Northern blot analysis detected the expression of this mRNA 
only in skeletal muscle (Fig. 14, probe F). This discrepancy 
might be due to the high sensitivity of RT-PCR compared to 
Northern blot analysis. A similar inconsistency has been 
found in the studies of human muscle PFK (hmPFK) gene: 
although this gene was shown by RT-PCR to be expressed in 
all seven human tissues examined, including skeletal muscle, 
liver, and kidney, its expression was not detected by 
Northern blot hybridization in liver, placenta, pancreas, 
stomach, and reticulocytes (Nakajima et al., 1990).
Oligo L, the upstream primer specific to exon IC showed 
that there are two mRNAs expressed in skeletal muscle (Fig. 
15B). The larger one corresponds to mRNA-bl. In addition to 
the bl product, a smaller PCR product of the skeletal muscle 
RNA was amplified by RT-PCR with primer L (Fig. 15B). This 
smaller DNA product (b2) was gel purified and cloned into 
pBluescript II KS(+) vector which was digested with EcoRV 
restriction endonuclease (Marchuk et al., 1991). The 
sequence of the insert (designated as cDNA-7) is shown in 
Figure 11. Comparison of the sequence of this clone and the 
rmPFK genomic sequence indicates that part of the 5' UTR of
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Figure 15. Analysis of the tissue-specific expression of 
the six mRNAs of the rmPFK gene by RT-PCR using 
thermostable reverse transcriptase Tth DNA polymerase. One 
jig of poly (A)* RNA from each rabbit tissue was reverse 
transcribed with Tth DNA polymerase using the 3' primer 
(oligo see Fig. 12 for diagram and Table 2 for 
sequence). The reverse transcription reaction mixture was 
aliquoted into four tubes. Each of the four 5' primers was 
then added along with PCR mixture to each tube: Primer K 
in ( A ) ;  L in < » ) ; M in (C>; and N in ( D ) . The positions of 
these primers are shown in Fig. 12B and the sequences are 
in Table 2. PCR amplification was performed at 60°C for 1 
min and 95°C for 1 min for each cycle. A total of 35 cycles 
were carried out. The precipitated PCR product were 
analyzed on 3% agarose gels (3 parts of Nusieve agarose 
from FMC Bioproducts and 1 part of agarose I from Amresco). 
For RT-PCR in panel C, the PCR product was diluted 100 
times and reamplified for another 35 cycles. The expected 
sizes of the RT-PCR products are as following: a: 397 bp; 
bl: 64 6; c: 526 bp; D1: 503 bp; d2: 397 bp. The b2 band was 
cloned and sequenced and the expected size is 504 bp. (■) 
RT-PCR amplification of rabbit GAPDH mRNA using primers 
(GAPDH2 and GAPDH3, Table 2) complementary to the rabbit 
GAPDH cDNA (Putney et al., 1993). The expected sizes of the 
PCR product is 140 bp. M: skeletal muscle; L: liver; K: 
kidney; H: heart; B: brain; D: 100 bp DNA size ladder from 
GibcoBRL.
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mRNA-bl is removed by splicing as a 142 bp intron (Fig. 12). 
Therefore, alternative splicing gives rise to two rmPFK 
mRNAs, mRNA-bl and -b2, that contain exon 1C (Fig. 12).
Using oligo M, an upstream primer specific to mRNA-c, 
expression of this rmPFK mRNA was detected only in skeletal 
muscle (Fig. 15C). The RT-PCR product in panel C of Figure 
15 was reamplified, indicating that mRNA-c is expressed at a 
relatively lower level than the other rmPFK mRNAs. This is 
consistent with the weak signal detected in the Northern 
blot analysis (Fig. 14, oligo probe I),
RT-PCR using oligo N, an upstream primer specific to exon 
IE, showed two predominent products corresponding to mRNA-dl 
and -d2 (Fig. 15D). As mentioned above, these two mRNAs are 
derived from alternative splicing; exon IB is retained in 
mRNA-dl but not in mRNA-d2 (Fig. 12). The expression of 
mRNA-d2 was detected in all five tissues examined. However, 
mRNA-dl was not detected in liver and kidney, indicating 
that exon IB is retained in skeletal muscle, heart, and 
brain mRNA, but not in mRNA from kidney and liver (Fig.
15D). These results are consistent with the Northern blot 
analyses: rmPFK mRNAs containing exon IE (mRNA-dl and -d2, 
Fig. 12) were detected in all five tissues when probe J was 
used (Fig. 14). However mRNAs containg exon IB including 
mRNA-d2 (Fig. 12) was not detected in liver and kidney 
tissues (Fig. 14, probe G).
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The tissue-specific expression patterns of the six rmPFK
mRNAs are summarized and shown in Fig. 12.
I d e n t i f i c a t i o n  o f  t h o  t r a n s c r i p t i o n  s t a r t  s i t a  o f  
t b o  d o w n s t r o a n  p r o n o t s r
The transcription start site of the proximal promoter 
(Pa) that gives rise to mRNA-a was determined by 
both primer extension and SI mapping (Fig. 16). The 
primer extension study using M-MLV reverse transcriptase 
mapped a major site exactly at the 5' end of cDNA-1 and 
several minor sites (Fig. 16A). The SI mapping 
experiment mapped a major start site in the vicinity of 
the major site mapped by primer extension, along 
with some minor sites (Fig. 16B), Together, these results 
indicate that the proximal promoter of the rmPFK gene 
initiates transcription at a major site 66 bp upstream of 
the ATG translation initiation codon, specifically at 
the A residue in the 5'-GCCAGTCT-3' sequence, along with 
several minor sites. No TATA box is found -20 to -30 bp 
upstream of these start sites. The sequence surrounding 
the major start site (GCCAGTCT) is homologous to the 
functional initiator element (CTCANTCT) found in the TATA- 
less promoter of the murine terminal nucleotidyl transferase 
gene (Smale et al,, 1990). Multiple start sites are also 
characteristic of many TATA-less promoters (Dynan, 1986).
For example, the human Ha-ras gene has a TATA-less promoter 
and initiates transcription
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Figure 16. Determination of transcription start sites of 
the proximal promoter of the rmPFK gene. (A) Primer 
extension. The primer extension reaction was carried out 
with 8 pg of rabbit muscle poly(A)+ RNA. Primer F (panel C 
for position and Table 2 for sequence) used in the primer 
extension was 5'-end labeled with polynucleotide kinase and 
(Y-W P]ATP. (B) SI mapping. Probe A was generated by 
annealing the labeled primer F to the single stranded 
pRMPFK5'. The primer was extended with Sequenase. The 
extended products were subsequently digested with Pstl. The 
single stranded probes were subsequently purified with 
alkaline agarose gel electrophoresis (Ausubel et al.r 
1993). 8 pg of rabbit muscle poly(A)+ RNA and 2x10* CPM of 
probe A were hybridized in the aqueous hybridization buffer 
overnight at 50°C. SI digestion (150 units/300 pi reaction 
mix) was carried out at 30°C for 1 hr. Both the primer 
extension product and the SI mapping mixture were analyzed 
on a 6% acrylamide sequencing gel. Size markers are 
sequencing ladders generated with primer A and single 
stranded DNA of pRMPFKS'. The arrow indicates the position 
of the major band in primer extension and SI mapping 
analysis. M: muscle.(C) Schematic diagram depicting the 
primer used in primer extension and probe used in SI 
mapping. The plasmid prmPFK5' was constructed by ligation 
of a 2.5 kb Sstl-SstI fragment of the rmPFK gene into the 
pBluescript II plasmid. The Sstl-SStI PFK gene fragment 
contains 5' flanking region and the first coding exon. The 
single stranded SI probe was prepared as described by 
Ausubel et al. (1993). Only mRNA-a will hibridize to probe 
A. The predicted probe fragment is diagramed under mRNA-a.
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at multiple start sites spead over a 90-base pair region (Lu 
et al., 1994).
D e r a i n a t i o n  o f  t r a n s c r i p t i o n  s t a r t  s i t s  o f  t h a  
p r o m o t e r  c l o s e  t o  t h a  T A T A A A A  s e q u e n c e
Since the 5'-ends of cDNA-2 and -5 are 28 bp downstream 
and 233 bp upstream, respectively of the TATAAAA sequence 
(Fig, 11), it is possibile that promoter(s) lie near this 
sequence. To determine the transcription start sites 
of such promoter(s), first SI mapping analysis was 
performed. A single stranded DNA probe of 680 bp was 
prepared with its 5' end located 80 bp downstream of the 
TATAAAA sequence (SI probe in Fig. 17E). The SI mapping 
results (Fig. 17A) showed two groups of protected 
fragments. The largest fragment in the first group (bl) at 
the top of the gel is about 230 bp upstream of the TATA 
sequence. This position is within 5 bp of the 5' end of 
cDNA-5 identified by anchored PCR using Tth DNA polymerase. 
In the genomic DNA, a TATTTAT sequence is 20 bp upstream 
of the S' end of cDNA-5 (5' end of exon IC in Fig. 13).
This sequence is AT rich, but is not a perfect match to 
the eukaryotic TATA box consensus sequence [TATA(A/T)A(A/T)] 
found 20 to 30 bp upstream of the transcription start 
site of many RNA polymerase II promoters (Breathnach and 
Chambon, 1981) .
The other group of fragments (x in Figs. 17A) is about 9 
to 14 bp upstream of the TATAAAA sequence. This position 
corresponds to a splicing acceptor site (S' end of exon IB),
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Figure 17. Determination of transcription start sites of 
the promoter close to the TATAAAA sequence of the rmPFK 
gene. (A) SI mapping. Probe B (depicted in panel E) was 
generated similarly as probe A (see legend to Fig. 11), 
except labeled primer G, instead of primer F, was used. 
Primer G was extended with Sequenase using the single 
stranded pRMPFKS' as template. The extended double stranded 
DNA products were subsequently digested with SstI, rather 
than PstI restriction enzyme. The single stranded probe was 
then isolated from alkaline agarose gel (Ausubel et al., 
1993). 8 pg of rabbit muscle poly(A)+ RNA and 2xl05 CPM of 
probe B were also hybridized in the aqueous hybridization 
buffer overnight at 50°C. (B) Primer extension using M-MLV
reverse transcriptase. The primer extension reaction was 
carried out with 8 pg of rabbit muscle poly(A)+ RNA and 
2xl05 CPM of 5' end labeled primer G (panel E for position 
and Table 2 for sequence). SI digestion (150 units SI 
nuclease/300 pi reaction mix) was carried out at 30°C for 1 
hr. The SI mapping mixture were analyzed on a 6% acrylamide 
sequencing gel. (C) Primer extension using thermostable 
reverse transcriptase Tth DNA polymerase. Primer and RNA 
used were the same as in (B) (for detail, see Materials and 
Methods) Size markers are sequencing ladder using primer B 
and single stranded DNA of pRMPFKS'. M: muscle. (D)
Possible secondary structure in the 5' UTR of cDNA-2 as 
predicted by the Fold algorithm in the GCG program (Zuker 
and Stiegler, 1981; Frier et al., 1986). (I) Primer G
(complementary to exon IB) and the SI probe used. The 
construction of prmPFKS1 is described in the legend of Fig. 
16. The protected SI probe fragments (bl and x) are 
diagramed under individual rmPFK mRNA. mRNA-a and mRNA-d2 
are not complementary to this SI probe because they do not 
contain exon IB.
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which is 11 bp upstream of the TATAAAA sequence. This 
splicing junction is common to mRNA-b2, -c, and -dl (Fig. 
17E) .
The primer extension analysis also revealed multiple 
products (Fig. 17B). The bl band lie about 230 bp upstream 
of the TATAAAA sequence, consistent with the SI mapping 
results. Therefore, the rmPFK gene likely contains a 
promoter that initiates transcription at several sites about 
230 bp upstream of the TATAAAA sequence. This promoter is 
designated promoter b.
Primer extension generated several products between bl 
and y bands in Fig. 17B. These primer extension products may 
represent mRNAs such as mRNA-dl, that has extra 5' exons 
(exon IE in this case) spliced onto exon IB (Fig. 12). SI 
mapping of these mRNAs resulted in protected fragments 
corresponding to the 5' end of exon IB, the splicing 
junction (x in Fig. 17A). However, I can not rule out the 
posibility that these primer extension products are 
artifacts due to the secondary structure in mRNA-bl. 
Nevertheless, the size of these products are unlikely 
indicative of transcription start sites when compared to the 
size marker using genomic DNA sequencing ladder, because SI 
analysis did not show bands at the corresponding size.
Finally, primer extension analysis showed there is a 
strong band (band y in Fig. 17B) about 28 bp downstream of 
the TATAAAA sequence. The 5' end of cDNA-2 identified by
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anchored PCR using M-MLV reverse transcriptase is also at 
this site. However, the SI mapping results (Fig. 17A) showed 
that there is no band downstream of the TATAAAA sequence, 
particularly 28 bp downstream of the TATA-1 sequence.
To address this discrepancy, primer extension was carried 
out at 65°C using a thermostable reverse transcriptase, the 
rTth DNA polymerase (Fig. 17C). The results of this primer 
extension are similar to that using M-MLV reverse
transcriptase, except that there is no strong band about 28
bp downstream of the TATAAAA sequence (Fig. 17C). This is 
consistent with the SI analysis (Fig. 17A) . Therefore, it is 
very unlikely that there is a transcription start site 28 bp 
downstream of the TATAAAA sequence. It is possible that the
y band in the primer extension using M-MLV reverse 
transcriptase (Fig. 17B), and the cDNA-2 identified by the 
anchored PCR also using M-MLV reverse transcriptase resulted 
from the prematurely terminated reverse transcription 
reaction. This may be due to possible secondary structure in 
the 5' UTR of the mRNA. The fold algorithm in the GCG 
program (Zuker and Stiegler, 1981; Freier et al., 1986) 
predicted stem-loop structures in this region (Fig. 17D). In 
addition, anchored PCR using thermostable Tth DNA 
polymerase did not identify cDNA-2.
DISCUSSION
Previously, two cDNAs for the rabbit muscle PFK gene has 
been cloned (Li et al., 1990). These two cDNAs have an
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identical coding region, but their 5' UTRs are different. In 
one of the cDNAs, an intron of 1.7 kb is removed by splicing 
(Li et al., 1990). These two cDNAs could be derived from two 
promoters, or from one promoter and alternative splicing. In 
addition, the tissue specificity of the rmPFK mRNAs have not 
been determined.
First in this report, six cDNAs for the 5* UTR and the 5* 
portion of the coding region of the rmPFK mRNAs were cloned 
(Fig. 12). These cDNAs have the same translation initiation 
codon as the full length cDNAs cloned by Li et ai. (1990). 
Thereore, the cDNAs cloned here likely have the same open 
reading frame as the full length cDNAs of Li et al. (1990). 
The six cDNAs cloned are consistent with two rmPrK cDNAs 
cloned previously (Fig, 10; Li et al., 1990): cDNA-1 in this 
study contains the entire 5f UTR of cDNA-A, while cDNA-5,
-7, -6, and -3 (from 3' to 5 ’) all contain the entire 5' UTR 
of cDNA-2 (Fig. 12 and Fig, 10) and each has more 5' 
sequence than the 5' UTR of cDNA-A of Li et al. (1990).
In addition, cDNA-4 has a 5' UTR that is not present in 
either of the two cDNAs of Li et al. (1990). This cDNA is an 
splicing variant of cDNA-3: exon IB (exactly the entire 5' 
UTR of cDNA-A of Li et al., 1990) is not retained in cDNA-3. 
Two more cDNAs are derived from alternative splicing: cDNA-5 
is a splicing variant of cDNA-7; more specifically, the most 
5' intron in the 5' UTR of cDNA-5 is retained, but is 
removed by splicing in cDNA-7 (Fig. 12). Southern blot
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analysis of rabbit genomic DNA digested with restriction 
enzymes indicates that rmPFK is a single copy gene (Knaak 
and Chang, unpublished data). The human muscle PFK gene has 
also been shown to be single copy (Sharma et al., 1990).
The transcription start sites of two downstream promoters 
of the rabbit gene have been mapped. Promoter a initiates 
transcription at a major site 86 bp upstream of the ATG 
translational initiation codon, along with several minor 
sites. The 5' end of cDNA-1 identified by anchored PCR is at 
the major start site mapped by primer extension and SI 
mapping. The transcription start sites of a second promoter 
reside at -2025 upstream of the ATG condon. The 5' end of 
mRNA-bl is at this site. Although the transcription start 
sites of the promoter(s) giving rise to mRNA-c (containing 
exon ID), mRNA-dl and -d2 (both containing exon IE) have yet 
to be determined. Because exon ID and exon IE are upstream 
of promoters a and b, they can not be transcribed from these 
promoters and must be transcribed from promoters further 
upstream. Therefore, the six rmPFK mRNAs are expressed by at 
least three promoters and by alternative splicing from a 
single copy gene.
The 5' end of cDNA-2 is 28 bp downstream of the TATAAAA 
sequence. Primer extension using M-MLV reverse transcriptase 
also showed a band at this position (Fig. 17B) . However, SI 
mapping analysis clearly showed no band at this position 
(Fig. 17A). Furthermore, primer extension analysis at 65°C
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using Tth DNA polymerase did not show a band at this 
position (Fig. 17C). Therefore, it is very unlikely that 
there is a transcription start site at this position. The 
reverse transcription reaction using M-MLV reverse 
transcriptase is probably prematurely terminated at this 
position, resulting in a band in the primer extension 
analysis and the 5* end of cDNA-2 at this position.
It is intriguing that there is no transcription start 
site 20 to 30 bp downstream of this TATAAAA sequence, since 
it matches the TATA box consensus sequence found about 25 bp 
downstream of transcription start site of many eukaryotic 
protein encoding genes (Breathnach and Chambon, 1981) . In 
addition, there are multiple putative binding site for 
transcription activators upstream of this sequence. For 
example, within 200 bp upstream of the TATA sequence there 
are three binding sites for the bHLH myogenic transcription 
activators, such as MyoD and myogenin (Weintraub et ai., 
1991).
There are several possibilities that there is no 
transcription start site downstream of this TATA sequence. 
First of all, there may be a specific repression sequence 
near the TATA sequence. Second, chromatin structure in this 
region might prevent transcription initiation. It has been 
shown in vitro that a minimal promoter containing the TATA- 
box is able to direct assembly of the transcription 
initiation complex onto the DNA template and initiate
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transcription (Buratowski et al., 1989). The binding of 
transcription factor TFIID to the TATA box is essential for 
transcription initiation. However, binding of TFIID to a DNA 
template containing a TATA box and subsequently the 
transcription initiation is severely inhibited after the 
nucleosome assembly (Workman et al., 1991; Meinsterernst et 
al., 1990) .
Recently, it has been shown human SWI/SNF complex can 
facilitate the binding of TATA-binding protein (TBP) to 
nucleosomal DNA, but only when the TATA box is in the 
favarable position (Imbalzano et al. (1994). These 
researchers constructed a DNA template of 14 9 bp containing 
two nucleosome positioning sequences (Shrade and Crothers,
1989) at the 5' end and the adenovirus major late promoter 
TATA box in the middle (PH MLT). The phasing sequence favors 
specific positioning of the histone core. They constructed 
two variant templates [PH MLT9(+3) and PH MLT(+6)] 
positioned the TATA box either 3 or 6 bp, respectively, 
closer to the phasing sequences. After nucleosome assembly, 
TBP can not bind to the TATA box in all three templates. 
Human SWI/SNF complex has been shown to facilitate the 
binding of TBP to the TATA box in PH MLT (+3) template. 
However, the complex does not facilitate the binding of TBP 
to the TATA box in the PH MLT and PH MLT(+6) templates 
(Imbalzano eC al., 1994). These data imply that if a TATA 
box is not at a favorable rotation relative to the
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nucleosome, even the SWI/SFN proteins can not facilitate the 
binding of TBP to the TATA sequence in a DNA template. The 
TATA sequence of the rmPFK gene could be in such a position. 
There are three sequences near the TATA sequence that match 
the consensus nucleosome positioning sequence. For example, 
sequence 5'-CCCCCAAT (28 downstream of the TATA sequence) 
matches the strong nucleosome positioning consensus sequence 
(G/C)3NN(A/T)3 (Shrade and Crothers, 1989).
After cloning six rmPFK mRNAs, X then studied the tissue- 
specific expression of these mRNAs by Northern blot analysis 
and RT-PCR technique. The results showed that these mRNAs 
are expressed with a complex pattern by both tissue-specific 
transcription and alternative splicing: mRNA-bl, -b2, and -c 
are skeletal muscle specific (Figs. 14 and 15). The 
expression of mRNA-a was detected only in skeletal muscle by 
Northern blot analysis (Fig. 14). However, RT-PCR experiment 
showed that this mRNA is also expressed in heart tissue 
(Fig. 15A). This discrepancy might be due to the high 
sensitivity of RT-PCR compared to Northern blot analysis. A 
similar inconsistency has been found in the studies of human 
muscle PFK (hmPFK) gene: although this gene was shown by RT- 
PCR to be expressed in all seven human tissues examined, 
including skeletal muscle, liver, and kidney, its expression 
was not detected by Northern blot hybridization in liver, 
placenta, pancreas, stomach, and reticulocytes (Nakajima et 
al., 1990). The rmPFK mRNA-dl was detected in skeletal
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muscle, heart, and brain tissues, but not in liver 
or kidney, while mRNA-d2 was detected in all five 
rabbit tissues examined (Fig. 15). The pattern of the 
tissue-specific expression of the rmPFK mRNAs 
described here is consistent with that of the rmPFK 
protein (Table 1; Tsai and Kemp, 1973), The rmPFK has been 
shown to be the predominant PFK in rabbit skeletal 
muscle. This isozyme has also been shown to be 
expressed at the protein level in brain, heart, kidney, 
and at very low level in the liver (Tsai and Kemp, 1973). 
Mhaskar and Dunaway (1995) studied the subuint 
abundance, protein synthesis, and steady state mRNA levels 
of the three PFK isozymes during rat neonatal brain 
development. Interestingly, from zero to 23 days after 
birth, the level of the M-type subunit, the protein 
synthesis, and the steady state level of rat muscle 
PFK mRNA increased simultaneously, indicating the 
steady state level of the M-type PFK mRNA plays an 
important role in controlling the abundance of the 
muscle type PFK isozyme. This is consistent with the 
correlation between the tissue-specific expression 
pattern of the rabbit muscle PFK at the protein 
leve (Tsai and Kempt, 1973) and at the mRNA level (this 
study).
There are similarities and differencies in the 
tissue-specific expression of mutiple mRNAs from the
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rmPFK gene and its human counterpart. The human gene 
expresses three mRNAs by two promoters and alternative 
splicing (Fig. 7; Yamasaki et al., 1991). The 
downstream promoter produces two hmPFK mRNAs, -a and -b. 
The hmPFK mRNA-a is a splicing variant of hmPFK mRNA-b: 
there is an 89 bp intron spliced out in mRNA-a.
The rmPFK mRNA-a and its human counterpart (hmPFK mRNA-b) 
are highly conserved (80% homology in the 5' UTR). The 
upstream sequences of the two genes have diverged 
significantly: a 750 bp region of human sequence and its 
rabbit counterpart have only 41% homology. The rmPFK 
mRNA-a and its human counterparts are both skeletal 
muscle specific as examined by Northern blot, 
although the rmPFK was detected in the heart by 
RT-PCR. The expression of the human counterparts were 
not examined in this tissue. The mRNA-c transcribed 
by the upstream promoter of the human gene is 
probably the counterpart of rmPFK mRNA-d2: both 
mRNAs were found expressed in all the tissues examined.
In the hmPFK mRNA-c, the intron in the 5'UTR is 
about 3.3 kb, while in rmPFK mRNA-d2, the intron is about 
2.8 kb. In the rabbit, there is a splicing variant of this 
mRNA, mRNA-dl, in which exon IB is retained in a tissue 
specific manner, more specifically retained in skeletal 
muscle, heart, and brain, but not in liver and kidney 
tissues (Fig. 12). There are no cloned human counterparts
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for the rabbit mRNA-bl, -b2, and -c. In mouse, only one 
promoter has been characterized for the muscle PFK gene 
(Gekakis and Sul, 1994), which is equivalent to the 
downstream promoter of the human and rabbit muscle PFK 
genes. Such nonconservative usage of alternative promoters 
has also been reported in the aldolase A gene. In the human 
gene there are three promoters (Gautron et al., 1991), while 
there are only two promoters in the mouse gene, with no 
equivalent known human upstream promoter (Stauffer et al.,
1990).
Multiple mRNAs with different 5' UTRs expressed from 
multiple promoters and/or alternative splicing as observed 
in rabbit and human muscle PFK genes have also been 
reported in other mammalian genes. For example, the gene 
from rat encoding a bifunctional enzyme 
6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 
has two tissue specific promoters, one muscle specific 
and the other liver specific (Darville et al., 1989). This 
enzyme catalyzes both the synthesis and degradation of 
fructose-2,6-bisphosphate, a potent regulator of PFK (El- 
Maghrabi et al., 1990). The human aldolase A gene contains 
three promoters, including a muscle specific one (Gautron et 
al., 1991). Interestingly, aldolase A is also involved in 
glycolysis.
The mouse y-glutamyltransferase gene expresses its six 
mRNAs from five promoters, three of which are kidney
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specific (Rajagopalan et ai., 1993; Sepulveda et al., 1994). 
The human carbonic anhydrase I gene contains two 
promoters with different tissue specificities 
(Brady et al., 1991). Multiple promoter usage has also 
been observed in mouse glucorticoid receptor gene (Strahle 
et al., 1992), rat dopamine-D2-receptor gene (Valdenaire et 
al., 1994), and rat liver alkaline phosphatase gene (Toh et 
al., 1989).
Multiple promoters of these genes may give an 
organism more flexibility to fine tune the regulation 
of the expression from these genes according to the 
physiological function of a given tissue. Multiple 
promoters may also serve as a safe guard to prevent 
shut-down of the gene expression when key promoter 
elements are mutated. In the case of rabbit PFKs, 
all three isozymes are expressed in brain and kidney, 
while in skeletal muscle, however, only the M type PFK 
is expressed. If the rmPFK gene has only one promoter, 
the skeletal muscle will suffer from PFK deficiency 
when the promoter is mutated in such a way that the 
expression of the gene is dramatically reduced. This 
might result in PFK deficiency disease like the Tarui 
disease. However, this can be prevented if the gene has 
multiple promoters. Although only one promoter of the 
rmPFK gene is active in rabbit kidney tissues, the 
down-mutation of the promoter will only result in
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reduced expression from the muscle gene. The 
Kidney will still have PFK activity because L type 
and C type PFKs are also expressed in Kidney.
SECTION II
PRIMER EXTENSION AT HIGH TEMPERATURE BY THERMUS 
THERMOPHILUS DNA POLYMERASE
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X H T R O D U C T Z O H
Primer extension is a method frequently used in 
conjunction with SI mapping or RNase protection analysis in 
determining gene transcription start sites. In this method, 
an RNA template is reverse-transcribed by either avian 
myeloblastosis virus (AMV) reverse transcriptase or Moloney- 
murine leukemia virus (M-MLV) reverse transcriptase. A 
drawback of this method is that secondary structure in the 
RNA template may cause the reaction to be prematurely 
terminated. To address this problem, Bailey and Davidson 
(1976) have reported the use of methylmercuric hydroxide to 
destabilize the RNA secondary structure. This compound is 
extremely toxic and hence inconvenient to handle. An 
alternative method is to raise the temperature of the 
extension reaction (Huibregste and Engelke, 1986; Shimimaye 
and Salvato, 1989). Elevated temperature would destabilize 
the secondary structure in the RNA template and increase 
primer extension specificity. Yet the upper temperature 
limit is about 50°C for both the M-MLV and AMV reverse 
transcriptases, due to the thermal inactivation of these 
enzymes. In my studies of the transcription start sites of 
the rabbit muscle phosphofructokinase (PFK) gene, I found 
that primer extension was prematurely terminated, even at 
50°C (see SECTION I). As predicted by the Fold algorithm in 
the GCG program (Zuker and Stiegler, 1981; Freier et al., 
1966), there is a putative secondary structure in the rabbit 
muscle PFK mRNA consisting of two stem-loops, including four
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consecutive G-C basepairs immediately upstream of where the 
primer extension stopped (Fig. 17 D). This prompted me to 
search for a thermostable reverse transcriptase which could 
perform primer extension at temperatures higher than 50°C.
Recently, thermostable DNA polymerase from Thermus 
aguaticus (Tag) has been shown to possess reverse 
transcriptase activity in reverse transcription-polymerase 
chain reaction (RT-PCR) (Jones, 1993; Jones and Foulkes, 
1989; Tse and Forget, 1990; Shaffer et al., 1990). The 94- 
kDa DNA polymerase from Thermus thermophilus (Tth) has been 
reported to possess even higher reverse transcriptase 
activity in RT-PCR experiment than Tag DNA polymerase (Myers 
and Gelfand, 1991) . However, primer extension products 
extended from cellular RNA by either Tag or Tth DNA 
polymerase have not been fully characterized other than by 
RT-PCR. Under the conditions described by Myers and Gelfand 
(1991), the Tth DNA polymerase was found not efficient 
enough for primer extension analysis of cellular RNA. 
Therefore, several conditions for primer extension with this 
DNA polymerase were studied using rabbit heart poly(A)+ RNA 
and a primer complementary to the rabbit glyceraldehyde 3- 
phosphate dehydrogenase (GAPDH) gene. Under the optimized 
conditions, primer extension with Tth DNA polymerase at 65°C 
was as efficient as that with M-MLV reverse transcriptase at 
50°C. More importantly, primer extension of the rabbit 
muscle PFK mRNA using Tth DNA polymerase at 65°C solved the 
problems caused by the RNA secondary structure (see SECTION
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I). This study established a protocol of primer extension to 
map transcription start sites at elevated temperature using 
the thermostable Tth DNA polymerase. It would also be useful 
for the first strand cDNA synthesis in procedures such as 
cDNA library construction, anchored-PCR (Loh et al., 1989), 
and rapid amplification of cDNA ends (RACE) {Frohman et al., 
1988) .
MATERIALS AND METHODS 
Iniyass
Tth DNA polymerase (2.5 units/pl) was purchased from 
Perkin Elmer Cetus Co. Superscript II reverse transcriptase 
(RNase H deficient, genetically engineered M-MLV reverse 
transcriptase) was purchased from Life Science Technologies, 
Inc. T4 polynucleotide kinase was purchased from New England 
Biolabs, Inc. Shrimp alkaline phosphatase was purchased from 
United States Biochemical Co.
Preparation of the oligonucleotide primer end sise 
marker
Primer RabGAPDH (5' OH-CATGTAGACCATGTAGTGGAGGTCAATG-OH 
3') was complementary to the 5' sequence of rabbit GAPDH 
cDNA (Putney et al., 1983). This oligonucleotide was 
prepared by DNA International, Inc. and purified by 
polyacrylamide gel electrophoresis as described (Sambrook et 
al., 1989). The purified oligo was 5' end-labeled with [y- 
32P]ATP and T4 polynucleotide kinase (Sambrook et al., 1989). 
Size markers were generated by digesting pBR322 plasmid DNA
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with Hpall restriction endonuclease, followed by 
dephosphorylation with alkaline phosphatase and 
5' end-labeling (Sambrook et al., 1989).
Poly (A) + RNA preparation
Total RNA from skeletal and cardiac muscle of 10 day old 
New Zealand white rabbits was extracted by homogenizing the 
tissue in guanidinium isothiocyanate, followed by cesium 
chloride gradient centrifugation (Chirgwin et al., 1979). 
Poly(A)+ RNA was purified from the total RNA by oligo(dT) 
cellulose column chromatography (Sambrook et al., 1989). The 
concentration of poly(A)+ RNA was determined by measuring 
the absorbance at 260 nm (A26O)•
Primer extension by Tth DNA polymerase
Primer extension by Tth DNA polymerase was carried out as 
described below or as otherwise stated in the individual 
figure legend. The hybridization mix (12 jil) containing 16.7 
mM Tris-HCl (pH 8.3), 150 mM KC1, 5xl04 CPM of primer 
RabGAPDH and 3 ng of rabbit poly(A)+ RNA, was heated at 75°C 
for 5 min to denature the RNA. After annealing at 65°C for 5 
min, the extension mix (8 )il) containing 2.5 mM MnCl2» 500 
HM each of dATP, dGTP, dCTP, and dTTP, and 5 units of Tth 
DNA polymerase was added, and the reaction was overlaid with 
20 ill of mineral oil. Primer extension was carried out at 
65°C for 1 hr in a Perkin Elmer Cetus thermocycler. After 
extension, the mineral oil was carefully removed, and the 
residual oil was further extracted with phenol/chloroform 
before precipitation (see below).
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Along with 20 pi of H2O, 105 pi of RNase reaction mix 
(100 pg/ml salmon sperm DNA, 20 pg/ml DNase-free RNase A) 
(Ausubel et al., 1993) was added to each primer extension 
reaction tube. RNase digestion was carried out at 37°C for 
15 min, followed by the addition of 15 pi of 3 M sodium 
acetate, pH 5.2. This mixture was extracted once with 
phenol/chloroform/isoamyl alcohol and precipitated with 
ethanol. Half of the primer extension products were analyzed 
as described (Ausubel et al., 1993).
Primer extension by H-MLV reverse trsnscriptese
Primer extension was performed basically as described 
(Ausubel et al., 1993), except that the extension reaction 
was carried out with 100 units of Superscript II reverse 
transcriptase at 50°C instead of 42°C. Three pg of poly(A)+ 
RNA from rabbit heart and 5xl04 CPM of primer were used.
Half of the reaction products were resolved on 6% 
polyacrylamide gels containing 7 M urea,
RESULTS AND DISCUSSION
In order to conduct primer extension at elevated 
temperature, it is necessary to find a thermostable reverse 
transcriptase. Tth DNA polymerase is a very attractive 
enzyme because it is thermostable and possesses higher 
reverse transcriptase activity than Tag DNA polymerase 
(Myers and Gelfand, 1991), These researchers have reported 
successful results using thermostable Tth DNA polymerase in 
RT-PCR to detect cellular RNA expression when 400 pg of 
total RNA has been used. They have optimized several
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reaction parameters for the reverse transcription using Tth 
DNA polymerase. For example, they found that Mn++ is a 
better cation than Mg++, However, using these conditions, 
only a very faint band was visible when the primer extension 
reaction was analyzed on a polyacrylamide gel (Fig, 19, lane 
1). These results suggest that under these conditions, the 
reverse transcription efficiency by Tth DNA polymerase is 
low and is useful only when the reverse transcription is 
coupled to the amplification by PCR,
In order to explore the possibility of using Tth DNA 
polymerase in mapping transcription start sites, I optimized 
the experimental conditions which improved the reverse 
transcription efficiency of this enzyme. First, I studied 
the performance of Tth DNA polymerase as a reverse 
transcriptase at different temperatures using GAPDH specific 
primer and rabbit heart poly(A)+ RNA. Although Tth DNA 
polymerase has been shown to possess reverse transcriptase 
at 70°C (Myers and Gelfand, 1991), this activity was reduced 
at increased temperature (Fig. 18). At 70°C and 75°C, only a 
very faint band is visible (Fig. 18, lanes 1 4  2). On the 
other hand, shorter bands were also present in addition to 
the band of 203 bp when the reaction was performed at 55°C 
and 60°C, albeit the reverse transcriptase activity of Tth 
DNA polymerase was higher at 60°C than at 65°C (Fig. 17, 
lane 4 vs lane 3). When the reaction was carried out at 
65°C, a predominant band of 203 bp was produced. Therefore,
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Figure 18. Performance of Tth DNA polymerase in primer 
extension at different temperatures. Primer extension was 
carried out at 75, 70, 65, 60, and 55°C for 60 min (lanes 
1, 2, 3, 4, and 5, respectively). In each reaction, 5x10* 
CPM of 5'-end labeled oligonucleotide primer complementary 
to the rabbit GAPDH cDNA and 3 pg of poly(A+) RNA from 
rabbit heart is used, and half of the primer extension 
product is loaded. M: DNA size marker generated by 
digesting pBR322 DNA with HpaXI restriction endonuclease, 
followed by dephosphorylation and S' end labeling with ly- 
32P]ATP and T4 polynucleotide kinase. Arrow indicates the 
primer extension product about 203 bp.
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subsequent primer extension reactions with Tth DNA 
polymerase were carried out at 65°C.
Next, I examined the effect of the extension time on the 
amount of the product extended. The results showed that 
longer extension times enhanced the intensity of the band, 
the one extended for one hr being the strongest (Fig 19, 
lanes 2-4).
Actinomycin D is routinely used in primer extension to 
prevent primers to form hairpin when AMV or M-MLV reverse 
transcriptase is employed. However our results showed that 
this antibiotic reduced the reverse transcription efficiency 
of Tth DNA polymerase (lane 1 vs lane 2, Fig. 20). Hence, 
this antibiotic is not recommended in the primer extension 
reaction when Tth DNA polymerase is employed.
Finally, I compared the products extended by M-MLV 
reverse transcriptase with those by Tth DNA polymerase. The 
results showed that there was no visible difference in 
intensity and mobility of the products extended by these two 
polymerases (Fig. 21, lane 1 vs lane 2). Primer extensions 
were carried out for €0 min with M-MLV reverse transcriptase 
at 50°C and for 60 min with Tth DNA polymerase at 65°C. 
Extension for one hour has been recommended in primer 
extension protocols for AMV or M-MLV reverse transcriptase 
(Sambrook et al., 1989; Ausubel et al., 1993). The results 
under conditions described here demonstrate that primer 
extension with Tth DNA polymerase was as efficient as that 
with M-MLV reverse transcriptase. Primer extension by
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Figure 19. Effect of extesion time on the primer extension 
by Tth DNA polymerase. Extension reaction was performed at 
65°C for 10, 30, and 60 min. (lanes 2, 3, and 4, 
respectively). Lane 1: primer extension under the 
conditions (at 70°C for 10 min) used by Myer and Gelfand 
(1991). M: DNA size marker and see legend to Figure 16 for 
detail.
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Figure 20. Effect of actinomycin on primer extension by Tth 
DNA polymerase. Extension reaction was carried out at 65°C 
for 60 min with (lane 1) and without (Lane 2) actinomycin 
(0.15 mg/ml). M: DNA size marker, same as in Figure 18.
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M 1 2 3
Figure 21. Comparison of primer extension of GAPDH RNA by 
Tth DNA polymerase and that by MMLV reverse transcriptase. 
Lane 1: primer extension of rabbit heart poly(A+) RNA by M- 
MLV reverse transcriptase; lane 2: primer extension of 
rabbit heart poly(A+) RNA by Tth DNA polymerase; lane 3: 
primer extension of rabbit skeletal muscle poly(A+) RNA by 
Tth DNA polymerase. In each reaction# 5x10* CPM of primer 
and 3 jig of poly(A+) RNA from rabbit heart, except lane 3 of 
panel B from skeletal muscle, is used. Half of the primer 
extension product is loaded in each lane. M: size marker, 
see Fig. 18 for detail. Arrow indicates the primer 
extension product about 203 bp.
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Tth DNA polymerase using poly(A)+ RNA Isolated from rabbit 
skeletal muscle as template also produced a band similar In 
mobility to those produced using poly(A)+ RNA from rabbit 
heart (Fig. 21).
In conclusion, I have optimized conditions to perform 
primer extension of cellular RNA at elevated temperatures 
using thermostable Tth DNA polymerase. Before optimization, 
only a faint band was visible (Fig. 19, lane 1). After 
optimization, a strong band was produced (Fig. 19 lane 4). 
Furthermore, primer extension using Tth DNA polymerase at 
65°C and M-MLV reverse transcriptase at 50°C produced bands 
similar in size and intensity (Fig. 21, lane 2 vs lane 1). 
This protocol might be useful not only in mapping 
transcription start sites, but also in the first strand cDNA 
synthesis for cDNA library construction, for anchored-PCR 
(Loh et al, 1969), or for rapid amplification of cDNA ends 
(RACE) (Frohman et al., 1988), especially when secondary 
structure of the template RNA may be a potential problem in 
the procedure.
CONCLUSIONS AND FUTURE STUDIES
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PFK catalyzes the ATP dependent phosphorylation of F-6-P, 
the rate-limiting step in glycolysis. This enzyme is very 
interesting to biochemists due to its importance in the 
glycolytic pathway and also its allosteric kinetic behavior 
responding to various metabolites (Dunaway, 1983). In 
addition, this enzyme is physiologically important. The loss 
of function of the muscle PFK gene results in Tarui disease 
(Tarui et al., 1965).
In mammalian tissues, PFK exists as homo- or hetero- 
tetramers of three distinct subunits. The three isozymes 
exhibit different kinetic properties (Foe and Kemp, 1985). 
The relative levels of these isozymes in a given tissue 
determine the composition of PFK tetramers and subsequently 
their allosteric behaviors in that tissue (Dunaway, 1983). 
Thus the molecular basis for the regulation of glycolysis in 
a given tissue lies in the control of the tissue-specific 
expression of the genes encoding these three isozymes.
To study the regulation of tissue specific expression of 
rabbit muscle PFK gene, the Chang laboratory has previously 
cloned the rabbit muscle PFK gene (Lee et al., 1987) and 
recently the two cDNAs of this gene (Li et al., 1990). These 
two cDNAs have an identical coding region, but divergent 5' 
untranslated regions. However, 1) we do not know whether 
these two cDNAs are derived from one or two promoters. If 
these cDNAs came from one promoter, their mRNAs would share 
the 5' end of the pre-mRNA. 2) the tissue specificity of 
these two cDNAs remains elusive.
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IDENTIFICATION OF SIX CDNAS FOR THE RMPFK GEMS
I have addressed the first question by cloning the 5' 
ends of the rmPFK mRNAs using anchored PCR technique. Five 
rmPFK cDNAs have been cloned by this technique. Using RT- 
PCR, an additional rmPFK cDNA has been cloned. Therefore, 
there are total of six rmPFK cDNAs (SECTION I). The 
sequences of the six cDNAs are consistent with the two 
previously cloned cDNAs (Li et al., 1990). For example, 
cDNA-l identified in this study contains the entire 5' UTR 
of cDNA-B of Li et al. (1990), while the 5' UTR of cDNA-A 
identified by Li et al. (1990) is present in four of the six 
cDNAs cloned in this study.
THE 8XX RMPFK mRMAS ARE EXPRE88ED FROM AT LEAST THREE 
PROMOTERS OF A SXMGLE GEME
Southern blot analysis of rabbit genomic DNA digested 
with restriction enzymes indicates that rmPFK is a single 
copy gene (Knaak and Chang, unpublished data). The human 
muscle PFK has also been shown to be a single copy gene 
(Sharma et al., 1990). Therefore, the six cloned rmPFK cDNAs 
are produced from a single gene.
We have mapped the transcription start sites of two 
downstream promoters of this gene. Promoter a initiates 
transcription at a major site 86 bp upstream of the ATG 
translational initiation codon, along with several minor 
sites (Fig. 16). The 5'-end of cDNA-l identified by anchored 
PCR is at the major site. The transcription start sites of a 
second promoter initiate transcription from several sites
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about 2 kb upstream of the ATG codon (Fig. 17). The 5'-end 
of cDNA-5 is at one of these transcription start sites. The 
transcription start sites of the promoter(s) giving rise to 
mRNA-c, mRNA-dl and -d2 have yet to be determined. Since the 
5' ends of these mRNAs are upstream of promoters a and b, 
they can not be transcribed from these promoters. Therefore, 
the rmPFK gene expresses these six mRNAs from at least three 
and possible four promoters. The promoter(s) that gave rise 
to mRNA-c, -dl, and -d2 can be mapped by both primer 
extension and SI mapping, techniques that successfully 
mapped the transcription start sites of promoter a and 
promoter b.
FOUR or THE SIX RMPFK mRNAS ARE PRODUCED BY 
ALTERNATIVE PRE-aRNA SPLICING
Alignment of the sequence of the cDNAs with that of the 
rmPFK genomic DNA showed that two alternative splicing 
events of two pre-mRNAs resulted in four of the six rmPFK 
mRNAs. First, mRNA-bl is a splicing variant of mRNA-b2; more 
specifically, the first intron in the 5' UTR was spliced out 
as an intron in mRNA-b2, but retained in mRNA-bl (Fig, 12),
Also mRNA-dl is a splicing variant of mRNA-d2; exon IB was
not retained in mRNA-d2 (Fig. 12). Alternative splicing
occurred in the 5' UTRs. The human muscle PFK gene has been
shown to express two of its three mRNAs by alternative 
splicing (Fig. 7; Yamasaki et al., 1991). However, the 
alternative splicing events occurred in different pre-mRNAs 
in the muscle PFK genes of the two species. In the human
109
gene, the pre-mRNA transcribed by the downstream promoter is 
alternatively spliced, while in the rabbit gene, the 
equivalent (mRNA-a) is not alternatively spliced, although 
5' UTR of the rmPFK mRNA-a and its human counterpart is 
highly conserved (82% homology in a region of 450 bp, 
including the first coding exon and 300 bp upstream of the 
ATG codon). The alternatively spliced mRNAs of the rmPFK 
gene are transcribed from promoter b and a promoter further 
upstream.
IT 18 UNLIKELY THAT THERE IS A TRANSCRIPTION START 
SITE 20 TO 30 BP DOWNSTREAM OP THE TATAAAA SEQUENCE
The 5' end of cDNA-2 is 28 bp downstream of the TATAAAA 
sequence. Primer extension using M-MLV reverse transcriptase 
also showed a band at this position (y in Fig. 17B).
However, SI mapping analysis clearly showed no band at this 
position (Fig. 17A) . Furthermore, primer extension analysis 
at 65°C using Tth DNA polymerase did not show a band at this 
position (Fig. 17C). Therefore, it is very unlikely that 
there is a transcription start site at this position. The 
reverse transcription reaction using M-MLV reverse 
transcriptase is probably prematurely terminated at this 
position, resulting in a band in the primer extension 
analysis and the 5'-end of cDNA-2 at this position.
It is intriguing that there is no transcription start 
site 20 to 30 bp downstream of this TATAAAA sequence, since 
it matches the TATA box consensus sequence. In addition, 
there are multiple putative binding site for transcription
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activators upstream of this sequence. For example, in the 
190 bp DNA between promoter b and the TATAAAA sequence, 
there are three binding sites for the bHLH myogenic 
transcription activators, such as MyoD and myogenin 
(Weintraub et al., 1991).
There are several possibilities to explain the apparent 
lack of a transcription start site downstream of this 
TATAAAA sequence. First of all, there may be a specific 
repression sequence near this sequence. This can be 
investigated by making a construct fusing the 
chloroamphenical acetyltransferase (CAT) reporter 3' to the 
rmPFK genomic DNA sequence 180 bp upstream and 80 bp 
downstream of the TATAAAA sequence, since the promoter b is 
about 200 bp upstream of the TATAAAA sequence and the splice 
site at the 3' end of exon IB is about 88 bp downstream of 
the TATAAAA sequence. Linker scanning mutants can be created 
based on this construct. Transfection of these constructs to 
myoblast C2C12 cells and subsequent CAT assay will probably 
reveal the effect of certain mutations at a specific 
sequence on the repression of transcription initiation 20 to 
30 bp downstream of the TATAAAA sequence, if there is a 
sequence-specific repressor of transcription initiation in 
this region of the rmPFK gene. In other words, certain 
mutation in this region will leads to transcription 
initiation, when a sequence-specific repressor is mutated.
Of course, such mutant should be examined to find out that 
gain of transcription initiation is not due to the creation
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of a positive element by the mutation. This can be done by 
mutate the putative repressor to other sequences.
Secondly, chromatin structure in this region might 
prevent transcription initiation. It has been shown in vitro 
that a minimal promoter containing the TATA-box is able to 
direct assembly of the transcription initiation complex onto 
the DNA template (Buratowski e t  al., 1989). The first step 
is the binding of transcription factor IID (TFIID) to the 
TATA-box, followed by the TFIIA, TFIIB, RNA polymerase II, 
and TFIIE. This complex is able to initiate transcription in 
the presence of four dNTPs. The binding of TFIID to the TATA 
box is essential for transcription initiation. However, 
binding of TFIID to a DNA template containing a TATA box and 
subsequently the transcription initiation is severely 
inhibited after the nucleosome assembly (Workman e t  al., 
1991; Meinsterernst et al., 1990) . However, the binding 
remains and potentiates transcription initiation if the 
nucleosome is assembled after the TFIID binds to the DNA 
(Workman and Roeder, 1987). Recently, it has been shown that 
purified yeast SWI/SNF protein complex can potentiate the 
binding of transcription activator GAL4 derivative to 
nucleosomal DNA (Cote e t  al., 1994). Imbalzano et al.(1994) 
have examined whether human SWI/SNF complex can facilitate 
the binding of TBP to nucleosomal DNA. These researchers 
constructed a DNA template of 149 bp containing two 
nucleosome positioning sequences (Shrade and Crothers, 1989) 
at the 5' end and the adenovirus major late promoter TATA
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box in the middle (PH MLT). The phasing sequence favors 
specific positioning of the histone core. They constructed 
two variant templates (PH mlt9(+3) and PH MLT(+6)) 
positioned the TATA box either 3 or 6 bp, respectively, 
closer to the phasing sequences. After nucleosome assembly, 
TBP can not bind to the TATA box in all three templates. 
Human SWI/SNF complex has been shown to facilitate the 
binding of TBP to the TATA box in PH MLT (+3) template. 
However, the complex does not facilitate the binding of TBP 
to the TATA box in the PH MLT and PH MLT(+6) templates 
(Imbalzano et al., 1994). These data imply that if a TATA 
box is not at a favorable rotation relative to the 
nucleosome, even the SWI/SFN proteins can not facilitate the 
binding of TBP to the TATA sequence in a DNA template. The 
TATAAAA sequence of the rmPFK gene could be in such a 
position. There are three sequences near the TATAAAA 
sequence that match the consensus nucleosome positioning 
sequence. For example, sequence 5'-CCCCCAAT (28 downstream 
of the TATAAAA sequence) matches the strong nucleosome 
positioning consensus sequence (G/C)3NN(A/T)3 (Shrade and 
Crothers, 1989).
If the nucleosome is repressing transcription, a naked 
DNA template of the above mentioned construct can be used 
which has a CAT reporter fused 3' to an rmPFK gene fragment 
about 180 bp upstream and 80 bp downstream of the TATAAAA 
sequence. This template should initiate transcription in in 
vitro transcription system using histone-depleted nuclear
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extract from rabbit muscle# since there are three putative
MyoD binding sites in this rmPFK gene fragment.
THE SIX RMPFK MRNAS ARE MOT EXPRESSED IN SAME TISSUE- 
SPECIFIC MANNER
Northern blot and RT-PCR analysis revealed that the six 
rmPFK mRNAs are expressed in a tissue-specific manner: mRNA- 
bl, -b2, and -c are skeletal muscle specific <Figs. 14 and 
15). mRNA-a was also found expressed only in skeletal muscle 
by Northern blot analysis (Fig. 14). However, RT-PCR 
experiment showed that this mRNA is also expressed in heart 
(Fig. 15A). This discrepancy might be due to the high 
sensitivity of RT-PCR compared to Northern blot analysis. 
mRNA-dl was only detected in skeletal muscle, heart, and 
brain tissues, but not in liver and kidney, while mRNA-d2 
was detected in all five rabbit tissues examined (Fig. 15). 
The hmPFK gene has also been shown by RT-PCR to be expressed 
in all seven human tissues examined (Nakajima et al., 1990).
The pattern of the tissue-specific expression of the 
rmPFK mRNAs described here is consistent with that of the 
rmPFK protein (Tsai and Kemp, 197 3). The rmPFK has been 
shown to be the predominant PFK in rabbit skeletal muscle. 
This isozyme has also been shown to be expressed in brain, 
heart, kidney, and minimally in liver tissues (Tsai and 
Kemp, 1973). A similar pattern of expression of the muscle 
type PFK has also been shown in humans (Dunaway et al.,
1988) and in rats (Dunaway and Kasten, 1987).
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THE DIFFERENT 5' UTRS OF THE SIX RMFFK aRNAE HAT FLAT 
A ROLE IN THE STABILITY AND TRANSLATIONAL EFFICIENCY 
OF THESE aRNAS
The six different mRNAs of the rmPFK gene have 
different 5' UTRs. There is one short open reading frame 
(ORF) of 72 nucleotides in the 5' UTR of mRNA-c (for 
sequence, see Fig. 11). In the 5' UTR of mRNA-bl, there 
are three ORFs of 15, 12, and 60 nucleotides. Four short 
ORFs in the 5' UTR of the yeast GCN4 mRNA have been shown 
to regulate the translation of the GCN4 ORF {Hinnebusch et 
al., 1993). Whether the short ORFs in the 5' UTRs of the 
rmPFK mRNA-bl and mRNA-c play any role in the stability 
and translational efficiency of the PFK ORF is not known.
This could be addressed by the following experiments.
The 5' UTRs of the different rmPFK cDNAs will be fused 5' 
to the CAT coding region. These chimeras will be driven 
by a common promoter, such as adenovirus major late 
promoter. The stabilities of the chimeric mRNAs can be 
deduced by examining the levels of these chimeric 
mRNAs before and at different times after the 
addition of Actinomycin D, which stops transcription 
by RNA polymerase II. The effects of these different UTRs 
on the translational efficiency can also be studied using 
these constructs. The CAT enzyme activity of the different 
constructs and the steady state level of the mRNAs would 
reveal the translational efficiency of the different 
chimeric mRNAs.
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PRIMS It BXTEHSIOM AT HIGH TEMPERATURE USING 
THERMOSTABLE TTH DMA POLYMERASE
In this dissertation research, I have developed a 
protocol tor primer extension at high temperature. Primer 
extension at 50°C of rmPFK around the TATAAAA sequence 
resulted in prematurely terminated products when M-MLV 
reverse transcriptase was used. Higher temperature should 
destabilize the secondary structure and reduce the artifact. 
However, both AMV and M-MLV reverse transcriptases have been 
found inactivated at temperatures higher than 50°C (Gibco 
BRL catalog). Tth DNA polymerase has been reported to 
possess reverse transcriptase activity and can tolerate high 
temperature (Myers and Gelfand, 1991). Primer extension 
under the conditions in the existing protocol (Myers and 
Gelfand, 1991) resulted in a very faint band. After 
optimization, primer extension using Tth DNA at 65°C 
produced a band similar in size and intensity to that using 
M-MLV reverse transcriptase at 50°C. Using the optimized 
protocols developed in this study (SECTION II), primer 
extension at 65°C using Tth DNA polymerase resolved the 
problem caused by the secondary structure in the rmPFK mRNA 
(SECTION I). The improved method may be useful for other 
procedures such as cDNA library construction and anchored 
PCR. The usefulness of this protocol has been shown in 
anchored PCR experiment described in SECTION I of this 
dissertation.
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APPENDIX
RESTRICTION MAP OF THE 5 ’ FLANKING REGION OF THE 
RABBIT MUSCLE PHOSPHOFRUCTOKINASE GENE
This map was generated using the GCG software (Zuker and 
Stiegler, 1981).
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Enzymes that do cut:
AccX AciZ AflZZZ Age z Alul Alwl Alw21I AlwNZ
Apal ApaBZ Apol Aval Avail Avrll Ban I Ban 11
Bbal BbvZ BccI Bceaaz Beef I Beg I BfaZ Bgll
Bpml BpulOZ B*al BsaAZ BsaHX BaaJI BsaHZ BabZ
BscCZ BseRZ Bag I Bail BsiEI Ball Bam I BsmAI
BamFI BsoFI Bsp24I Bspl2*CI BapEI BspGI BspMZ Bari
BsrBX BerDZ BsrFZ BatXI Bsu361 Cacti CjeZ CjePI
CviJZ CviRI OdeZ DpnX DraZ Drain DrdZ DrdIZ
Dsal See I Eagl Eamll05Z Bari BCil ECONI EcoOlOBI
EC OR I ICORZI Faul FokZ FspI GdiXI Hael Ha* 11
Haalll Hgal Khal Hindi Hinfl Hpal HphI Kpnl
HaaZZ MaelZl KboIZ Mnll Mae I Mall Map I MspAlI
MwoX NarZ Hcil IlcoZ Nhel NlaZZI NlalV NruZ
Nap I PflMI Plel PmlZ PahAI PapSII Pat z PvuII
Rcaz RleAZ Rsax Sad Sad I Sap I SautSZ Sau3AI
ScrFZ SfaNI Sfcz Smal Srf I StuI StyZ TaqZ
TaqZZ TfiZ Thai Tael Tsp4SI TapSOSI Tthlllll Xbal
XmnI
Enzyme* Ichat do not cut:
AatZZ Aflll ■ Alw44I AacI Bael BamHI Bell Bgll I
Bpull02Z BsaBZ BsmBI BapLUllI BarG I BasHll Batll07Z BatEIZ
BstYZ ClaZ Eeo47III Eco57I EcoRV Fael HgiEII HindiII
MluZ HmeZ Mad Muni Hdel NgoAIV Hot I Nail
NapV Pad PflllOlZ Pmel P*pl40«I PvuZ Rarll Sail
ScaZ SexAZ Sfil Sgf I SgrAI SnaBI spei SphX
Saet3B7I SspI Sun I Swal T t h m i VspI XcmZ xhol
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